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The epidemiology of bovine herpesvirus 1 (BHV1) infection in Norfolk
was studied by scrutinizing records of submissions to Norwich
Veterinary Investigation Centre and undertaking a cross-sectional
analysis of serological findings from breeding herds in a disease
monitoring scheme. Longitudinal studies examined the feasibility of
eliminating BHV1 infection from individual herds by a test-and-cull
programme and of maintaining seronegative status by employing
security measures including serological screening of replacements.
Alternative strategies were adopted in two heavily infected herds. A
review of the appropriate literature and a description of the Norfolk
cattle industry are also presented.
Thirteen incidents of BHV1 fetopathy and 83 outbreaks of systemic
infectious bovine rhinotracheitis (IBR), including 13 clinically mild
low morbidity recrudescences in dairy herds, were confirmed between
1980 and 1989. These affected about 11 per cent of dairy herds and
five per cent of suckler herds. Outbreaks occurred mainly during the
winter months in rearing/fattening herds but throughout the year
amongst adult breeding cattle. BHV1 antibodies were present in 510
(26.7 per cent) of 1908 sera and 122 (44.5 per cent) of 274 herds
tested. There were no significant differences in antibody prevalence
between herd types or between systemic illness and fetopathy
submission categories but fewer sera from apparently healthy cattle
were seropositive (Pc.001). Antibody prevalence increased
significantly with age after three years.
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BHV1 antibodies were detected in the sera of 639 (15.1 per cent)
cattle from 4219 aged at least two years in 56 scheme herds with no
history of clinical IBR or IBR vaccination; almost 50 per cent of
cattle aged 10 years or more were seropositive. Antibody prevalence
amongst purchased cattle was much greater than in homebred cattle
(Pc.001 in dairy herds, P<.05 in suckler herds). Reactors were
present in 40 of the 56 herds: in seven herds more than 40 per cent
of adult cattle were seropositive. In these high prevalence (HP)
herds most cows seroconverted to BHV1 within two years of first
calving whereas there was virtually no evidence of active infection
in the 33 low prevalence (LP) herds. Maternally derived antibodies
waned by about six months and young stock in infected herds
subsequently remained seronegative provided they were kept apart from
the cows and external sources of infection.
BHV1 infection was readily eliminated from LP herds; serological
freedom was retained during surveillance periods of up to four years
by strict adherence to disease security rules. The repeated use of
inactivated BHV1 vaccine to reduce virus shedding appeared to prevent
further spread within an HP suckler herd; combined with partial
segregation it was also used in the successful phased removal of
reactors from an HP dairy herd within 30 months.
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PREFACE
Bovine herpesvirus 1 (BHV1) is responsible for a broad spectrum of
disease manifestations in cattle, the most important being infectious
bovine rhinotracheitis (IBR) and infectious pustular vulvovaginitis
(IPV)/infectious pustular balanoposthitis (IPB). The latter genital
tract conditions were not encountered during these investigations and
are alluded to only briefly in the text. To avoid the
inconsistencies with nomenclature that are apparent in much of the
literature, the term "BHV1" has been used throughout when referring
to the causal virus and "IBR" (or IPV/IPB) when describing the
clinical disease.
In recent years there has been growing interest in the control and
elimination of BHV1 infection, particularly in Europe, because of its
significance to international trade in live cattle, semen and embryos
in addition to the potentially serious economic effects of clinical
disease outbreaks. Despite its importance, there remains a dearth of
information about the epidemiology of this common endemic infection -
detailed observational studies have been particularly lacking.
The work presented in this thesis utilizes available field data to
examine the natural history of BHV1 infection in the numerically
small, but none the less important, cattle population of Norfolk
during the decade spanning its introduction into the county to the
first steps in its elimination.
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CHAPTER 1: REVIEW OF THE LITERATURE
BHV1 infection has been the subject of several fairly comprehensive
published reviews, notably those by Gibbs and Rweyemamu (1977), Kahrs
(1977), Yates (1982), Wyler and others (1989) and Straub (1990a). In
keeping with the general theme of this dissertation the present
review concentrates mainly on those aspects of BHV1 infection that
relate to its clinical features, epidemiology, control and
eradication.
HISTORY AND OCCURRENCE
The respiratory form of BHV1 infection was first observed in beef
feedlots in Colorado, USA in 1950 (Miller 1955) and subsequently
described as an apparently new upper respiratory disease of dairy
cattle in California in 1953 (Schroeder and Moys 1954). The clinical
condition was formerly named as "infectious bovine rhinotracheitis"
by McKercher and others (1955). The causal agent, initially isolated
in tissue culture by Madin and others (1955) and identified as a
herpesvirus by Armstrong and others (1961) was the first virus
(Mohanty 1978) shown definitely to cause respiratory infection in
cattle.
Gillespie and others (1959) found that the virus causing IBR was
serologically indistinguishable from that causing a mild
transmissible venereal disease of cattle recognised in Central Europe
and North America since the 19th century. This genital tract
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condition is now generally known as "infectious pustular
vulvovaginitis" (Kendrick and others 1958); the analagous clinical
condition in bulls is usually termed "infectious pustular
balanoposthitis" (Studdert and others 1964).
Following its emergence in the USA, IBR was soon identified elsewhere
including: New Zealand (Webster and Manktelow 1959), Germany
(Grunder 1960), Canada (Studdert and others 1961), Britain
(Darbyshire and others 1962) and Australia (Snowdon 1964). This
disease was uncommon and economically insignificant in Britain during
the 1960s and early 1970s (Wiseman 1988) compared with IPB and IPV
(Huck and others 1971, Collings and others 1972, Deas and Johnston
1973) which carried the serious potential risk of being transmitted
in semen from artificial insemination (AI) studs. However, with the
introduction of strict control measures in AI centres (Lucas 1986)
IPB/IPV was rarely seen in Britain after the 1970s (Edwards 1983,
Edwards 1988).
In contrast to the decline of IPB/IPV, there was a sharp increase in
the incidence and severity of IBR in Britain after 1976 (Edwards
1988): outbreaks in the north east of Scotland were clinically
indistinguishable from those first described in the USA feedlots
during the 1950s (Wiseman and others 1978, Cuthbertson 1979).
Reports of similar outbreaks followed from the rest of Britain (Anon
1979) and were also described in continental Europe where a virulent
field strain causing severe IBR had been seen since the early 1970s
(Straub 1978, Wiseman and others 1979). BHV1 now has a worldwide
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distribution and is endemic amongst most European countries although
Norway, Finland and Sweden are almost free from infection and it has
been virtually eradicated from Denmark and Switzerland (Ackerman and
others 1990a).
AETIOLOGY
BHV1 is classified as an alphaherpes virus, a subfamily that also
includes herpes simplex virus and Aujeszky's disease virus (ADV).
These all grow rapidly, are highly lytic and produce acute disease
followed by life-long latent infection (Studdert 1989). The BHV1
genome contains double-stranded DNA; the icosahedral nucleocapsid
consists of 160 capsomeres surrounded by a 1ipid-containing envelope
to form somewhat pleomorphic virions 150 - 200 nm diameter (Gibbs and
Rweyemamu 1977, Wyler and others 1989). The virus penetrates the
host cell by fusion with the plasma membrane and replicates in the
nucleus.
BHV1 is stable for up to a month at 4°C and over a wide pH range
(6.0 - 9.0) but is inactivated within 21 minutes at 56°C (Griffin and
others 1958) and very susceptible to lipid solvents and common
disinfectants including 0.5 per cent sodium hydroxide, one per cent
phenol derivatives and one per cent quaternary ammonium bases (Straub
1990a). It is stable in extended semen for several days at room
temperature and can survive five freeze-thaw cycles without a
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significant drop in titre (Drew and others 1987). It is potentially
capable of contaminating virus-free semen when stored in the same
container (Krpata 1982).
Elazhary and Darbyshire (1979) examined the aerosol stability of BHV1
suspended in calf nasal secretions. They found that it survived in
the atmosphere for at least three hours giving it the potential for
airborne transmission, particularly under intensive housing
conditions; low temperature (6°C) and a high relative humidity (RH)
of 90 per cent were most favourable, with a lower RH required with
increasing temperature. According to Straub (1990a) BHV1 can survive
in the environment for 30 days in winter and inside buildings for six
to 13 days (winter) and five to nine days in spring.
BHV1 isolates all exhibit the same serotype in cross neutralisation
tests, regardless of whether they are derived from IBR or IPV cases;
vaccine and virulent strains are similarly antigenically
indistinguishable (Homan and Easterday 1981). However, the use of
restriction endonuclease analysis and selective reactivity of
monoclonal antibodies and viral protein patterns (Misra and others
1983, Metzler and others 1985) has demonstrated five virus subtypes:
1, 2a, 2b, 3a, 3b. Subtype 1 is generally considered to be
"IBR-like" and subtype 2 "IPV-like" but in their review, Wyler and
others (1989) concluded that such references largely reflected
evolutionary history and noted that it was still not possible to
establish a strict correlation between clinical origin of isolates
and their molecular subtype.
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Edwards and others (1990) classified British isolates from the 1960s
as type 2b but found predominantly type 1 (resembling the prototype
USA Colorado strain) and occasional type 2b from 1977 onwards; types
2a and 3 were not detected; only type 2b was found in Northern
Ireland. The close similarity between isolates from severe IBR
outbreaks in Europe in the 1970s and those in the USA in the 1950s
led Wiseman (1984), Nettleton (1986) and Edwards and others (1990) to
conclude that a virulent strain of BHV1 (subtype 1) was introduced
into Europe and the United Kingdom during the 1970s with imports of
infected cattle, particularly Holsteins (Msolla and others 1981) from
North America.
CLINICAL AND PATHOLOGICAL FEATURES
The effects of BHV1 infection can vary from mild or inapparent
illness to severe and fatal disease (Kahrs 1977). This wide
diversity of clinical outcome appears to be determined
multifactorial^ by virus strain, route of exposure, immunological
status, age susceptibility and environmental factors (Kahrs 1977,
Blood and Radostits 1989a).
IBR is economically the most important clinical entity (Straub
1990a). The incubation period for field cases is probably as long as
a week (Wyler and others 1989); all ages and breeds of cattle are
susceptible but natural disease occurs mainly in animals over six
months old (Blood and Radostits 1989a, Straub 1990a). Clinical
descriptions of severe disease from the USA in the 1950s (Schroeder
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and Moys 1954, Miller 1955) are essentially the same as those in
Britain during the late 1970s (Wiseman and others 1978, Cuthbertson
and Wood 1979, Wiseman and others 1980). There is pyrexia (up to
42°C), increased respiratory rate, persistent harsh cough, anorexia,
depression and a marked fall in milk production by milking cows. A
clear bilateral nasal discharge becomes thick and mucopurulent within
a few days of onset; conjunctivitis with profuse lacrimation is
usually present. The acute phase lasts for between five and 10 days
after which animals recover, although there may be loss of condition.
Mortality is usually low or negligible but morbidity is invariably
high: more than 90 per cent of cattle were affected in 10 of the 15
outbreaks described by Wiseman and others (1980). Secondary
bacterial infection, particularly with Pasteurel 1 a sp. or Mvcoplasma
bovis (Allan and others 1980, Yates 1982) can result in pneumonia
although this may not be apparent clinically (Wiseman and others
1980). The main pathological features of severe I BR include
necrotising rhinitis, pharyngitis and laryngotracheobronchitis with
extensive pseudomembrane formation (Allan and others 1980).
Clinically milder outbreaks of IBR have been described in the USA
(Abinanti and Plumer 1961), Britain (Dawson and others 1962) and
Ireland (Timoney and O'Connor 1971). These were characterised by
high morbidity and intense, generally bilateral conjunctivitis with
profuse lacrimation; congestion of the nasal mucosa and a serous to
mucopurulent nasal discharge were noted by Dawson and others (1962)
but respiratory signs were not reported by the other authors.
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Whilst IBR is well recognised as a disease of fattening beef cattle
(Wiseman 1980, Ross and others 1983) some authors including Peters
(1987) have suggested that IBR plays a significant role in
multifactorial enzootic pneumonia of younger calves (Blood and
Radostits 1989b). There is clearly synergism between BHV1 and
Pasteurella haemolvtica in the shipping fever complex of adult cattle
and feedlot calves (Yates 1982) and Briggs and others (1988) showed
that BHV1 infection can alter blood neutrophil function in calves and
thereby predispose to secondary bacterial pneumonia. However, Stott
and others (1980) found no evidence of BHV1 infection in their survey
of respiratory disease on a calf rearing unit in the south of England
in the 1970s and Verhoeff and Nieuwstadt (1984) reported only minimal
involvement by BHV1 in respiratory disease in calves on dairy farms
in Holland compared with respiratory syncytial virus and
parainfluenza type 3 (PI3) infections. The general view as expressed
by Stott and others (1987) and Kiorpes and others (1988) is that BHV1
is probably not an important cause of calf enzootic pneumonia.
There are few reports in the literature of IBR in young calves (Obi
and others 1981) but a systemic form of the disease can occur in
neonatal calves infected in utero during late gestation or shortly
after birth (Kahrs 1977). Ross and others (1983) described an
outbreak in three to four-day-old calves in which pathological
changes in the alimentary tract, including ulcerative oesophageal
lesions, were present in addition to respiratory tract disease. In a
similar incident of fatal systemic infection in very young calves,
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Higgins and Edwards (1986) also found ulcerative lesions in the upper
alimentary tract as well as focal necrotic liver lesions identical to
those described in aborted fetuses by Kendrick (1973). Grieg and
others (1981) described marked alimentary tract involvement and
ulcerative lesions with diarrhoea in calves with concurrent IBR and
bovine virus diarrhoea virus (BVDV) infection. Working with
experimentally infected calves, Peter and others (1966) identified
BHV1 virus in ulcerative alimentary tract lesions resembling those
seen with BVDV infection.
There are numerous reports in the literature of reproductive failure
associated with BHV1 infection. According to Wyler and others (1989)
up to 25 per cent of pregnant cattle can abort following an outbreak
of IBR and Gaines (1989) claimed that an explosive short-term
decrease in pregnancy rates can occur in herds immunologically naive
to BHV1. Owen and others (1964) and Kendrick (1973) demonstrated
that fetal death, with widespead focal necrotic lesions, can follow
maternal infection with BHV1 and subsequent viraemia, after a lag
phase of up to three months. Abortions may occur following either
clinical or non-clinical infection (Kahrs 1977). Experimental
infection with field strains of BHV1 or modified live virus IBR
vaccines can cause inflammatory lesions in the corpora lutea and
ovary leading to reduced progesterone levels, lowered conception
rates, early embryonic death and abortion (Miller and Van Der Maaten
1985, Van Der Maaten and others 1985, Miller and Van Der Maaten 1986,
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Smith and others 1990, Chiang and others 1990). Miller and others
(1991) reported that BHV1 isolates from aborted fetuses belonged to
subtypes 1 or 2a but not 2b.
In Britain, Wiseman and others (1980) observed that abortion occurred
during or after IBR outbreaks in four of 15 herds and Stubbings and
Cameron (1981) reported 15 abortions from a herd of 160 cows.
Laboratory surveys in Scotland (Nettleton and others 1981) and
Northern England (Murray 1990) suggested that up to about 12 per cent
of abortions may have been caused by BHV1 infection. However, a
similar study by Lucas and others (1986) at the Central Veterinary
Laboratory (CVL), Weybridge showed only minimal involvement of BHV1
in abortion. A more extensive investigation by Edwards (1988)
similarly indicated that reproductive failure was only a minor
consequence of BHV1 infection in British herds.
As mentioned earlier, some strains of BHV1 can cause the genital
tract conditions of IPV and IPB. The clinical features of these were
described in detail by Kendrick and others (1958) and Studdert and
others (1964). Infection is transmitted venereally causing a painful
inflammation by three days after mating; small pustules are present
on the mucosal surface of the oedematous vulva or on the penis or
prepuce. Temporary infertility can occur due to loss of libido and
pain (Gibbs and Rweyemamu 1977). Secondary bacterial infection is
uncommon and clinical recovery usually ensues within 10 - 14 days.
Concurrent respiratory and genital tract disease has been described
(Collings and others 1972) but appears to be very rare.
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An encephalitic form of BHV1 infection, first described in calves in
Australia by French (1962) has been tentatively attributed to subtype
3 virus (Wyler and others 1989) although Studdert (1990) designated
it "bovine encephalitis herpesvirus". The clinical condition, which
is manifested by nervous signs including circling, blindness and
opisthotonos (George 1991) has not been reported in Britain although
Higgins and Edwards (1986) found histological evidence of
non-suppurative encephalitis associated with BHV1 infection in a
suckler calf. Other diverse and unusual clinical syndromes
associated with BHV1 infection (Gibbs and Rweyemamu 1977) appear to
be of little significance in Britain.
DIAGNOSIS
Depending on severity, IBR may need to be clinically differentiated
from conditions such as infectious bovine keratoconjunctivitis,
pneumonic pasteurellosis, bovine malignant catarrh, mucosal disease,
calf diphtheria, allergic rhinitis and rinderpest (Gibbs and
Rweyemamu 1977, Kahrs 1977, Blood and Radostits 1989a). According to
Kahrs (1977), the presence of coalescing white necrotic pustules on
respiratory or ocular mucosa are the best aid to clinical diagnosis.
Cowdry type A inclusions (Jubb and others 1985) were described by
Crandell and others (1959) in the epithelial cells of the upper
respiratory tract of experimentally infected calves but because their
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presence is transitory they are generally considered to be of very
limited diagnostic value (Wyler and others 1989).
The isolation of virus in primary cell culture is the preferred
method of detecting BHV1 in the laboratory (Gibbs and Rweyemamu 1977,
Edwards and others 1983) and can readily be achieved by using nasal
or ocular cotton wool swabs collected into virus transport medium
(VTM) from early clinical cases (Nettleton and others 1983, Nettleton
1986). BHV1 induces a focal cytopathic effect within a few days of
inoculation although virus recovery can sometimes take up to 14 days
(Nettleton 1986). Other methods of virus antigen detection have been
developed to permit more rapid diagnosis. These include
immunofluorescence techniques (Terpstra 1979, Nettleton and others
1983), enzyme-linked immunosorbent assay (ELISA) (Edwards and others
1983), reverse passive haemagglutination (Edwards and Gitao 1987) and
immunoperoxidase staining using monoclonal antibodies (Rodriquez and
others 1989); a polymerase chain reaction test is also available
(Belak and others 1988).
Natural BHV1 infection or vaccination with modified live virus
vaccines activates humoral and eel 1-mediated components of the immune
system (Kahrs 1977). The latter plays the dominant protective role
via the T cell response, whereas direct humoral antibody mediated
neutralisation is only functional in cases of reinfection or
reexcretion after reactivation of latent virus (described later)
(Aguilar-Setien and others 1980, Wyler and others 1989, Straub
1990a). Despite this the humoral response has traditionally served
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as the indicator of prior infection. The serum neutralisation test
(SNT) using various techniques and standardisation criteria is the
most commonly performed method of antibody detection. Neutralising
antibody (IgM and IgG) to BHV1 can be detected in the serum at about
eight days after natural infection (Gibbs and Rweyemamu 1977) and
persists for at least five and a half years (Chow 1972).
Various other serological tests have been developed to overcome
problems with the SNT, namely its slowness, dependence on subcultures
and interference by non-antibody neutralising factors in some sera
(Lyaku and others 1990). The ELISA and a 24-hour SNT method have
proved equally sensitive and superior (Edwards and others 1986) to
the standard one-hour SNT (Frerichs and others 1982) and to an
indirect haemagglutination test (IHAT) (Kirby and others 1974). The
ELISA is now used routinely by many diagnostic laboratories and being
sensitive, rapid and economic it is ideal for large-scale surveys and
has also been used to test bulk milk samples in eradication
programmes (Wyler and others 1989, Gibson and Edwards 1991). A
system of standardisation has been proposed by Lyaku and others
(1990) to overcome problems associated with widely varying techniques
which have hindered the adoption of ELISA for international trade
purposes.
Colostrally acquired antibody, which is mainly IgGl, can persist
until six or seven months in the serum of calves that suck immune
mothers (Kahrs 1977, Bitsch 1984) and offers some (but not absolute)
protection against severe disease (Agui1ar-Setien and others 1980,
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Pastorst and others 1984). Maternally derived antibody (MDA) can be
distinguished from actively produced antibody by an intradermal test
(Forschner 1988, Brown and others 1990, Jungblut and others 1991).
This test measures cell mediated immunity via the delayed-type
hypersensitivity reaction (Brown and others 1990) in animals that
have experienced BHV1 infection and provides a potential means of
rapidly evaluating infected herds in the field. However, repeated
intradermal injections of BHV1 antigen can induce a serological
response in seronegative cattle (Thiry and others 1992).
TREATMENT AND VACCINATION
The use of broad-spectrum antibiotics, in addition to nursing care
and supportive therapy (Kahrs 1977) is invariably recommended to
control secondary bacterial infection during IBR outbreaks (Blood and
Radostits 1989a). Wiseman (1984) advocated antibiotic therapy for up
to 12 days, until the temperature of affected animals came down to
below 103°/.p
BHV1 vaccines with either live modified or inactivated virus and
either mono or polyvalent, have been in commercial use in many
countries for the past 30 years. In Britain, Wiseman and others
(1979) expressed concern over the limited options then available to
veterinary practitioners faced with severe outbreaks of IBR. Two
modified live virus vaccines: "Tracherine" (Smith Kline Animal Health
Limited) and "Nasalgen" (Wellcome Foundation Limited) were
subsequently licensed for use in Britain (Frerichs and others 1982).
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These vaccines were developed for intranasal administration
(McKercher and Crenshaw 1971) and were free of the abortifacient
properties of other live IBR vaccines. They proved to be superior
(Frerichs and others 1982) to the inactivated adjuvanted polyvalent
vaccine "Pneumovac Plus" (C-Vet Limited) that had previously been the
only biological product available in Britain for protection against
IBR. The immunogenicity of the latter vaccine was later enhanced
(Straub and Mawhinriey 1988). Inactivated vaccines are considered to
be only suited for prophylactic purposes (Straub 1990a); their use to
control virus shedding by latently infected cattle is described
later. In contrast, the live vaccines effectively prevent further
spread and reduce losses when used during an outbreak (Wiseman 1984,
Peters 1987, Van Donkersgoed and Babiuk 1991) by the prompt
production of interferon and secretory antibodies (IgA) on mucosal
surfaces (Wyler and others 1989, Straub 1990a).
PATHOGENESIS AND LATENCY
BHV1 enters the body via the mucous membranes of the upper
respiratory tract or conjunctiva (or genital tract with IPV/IPB);
oral infection has not been confirmed (Straub 1990a). After
experimental nasal infection the virus can be isolated from various
tissues including respiratory tract, eye, brain and intestines
(McKercher and others 1963). Simultaneous infection of genital and
respiratory tracts is very uncommon (Gibbs and Rweyemamu 1977,
Straub 1990a). Viraemia has rarely been reported and its role has
not been critically evaluated (Yates 1982, Straub 1990a): it is
-15-
probably weak and transient because of the small number of infected
leukocytes in the circulation (Peter and others 1966) but it provides
the apparent explanation for fetal or systemic neonatal infection
(Pastoret and others 1984).
After entering the neural cell at the nerve endings by fusion, naked
nucleocapsids are probably transported within the axon by retrograde
flow mainly to the trigeminal ganglia (respiratory tract infection)
or sacral ganglia (genital tract infection) where they establish
latent infection (Narita and others 1981, Ackermann and others 1982).
Wyler and others (1989) defined latency as "the silent persistence of
viruses in the body not detectable by conventional virological
procedures, with subsequent intermittent periods of excretion". The
ability of all BHV1 strains, including attenuated live virus vaccines
(Kahrs 1977, Yates 1982, Nettleton and others 1984) to establish
latent infection was first evident from experimental studies by
McKercher and others (1963) and Snowdon (1965). In view of this
phenomenon, it is generally accepted (Kahrs 1977) that any animal
with measurable humoral antibody is a virus carrier and potential
source of infection for susceptible herd mates, probably for life
(Bitsch 1973, Bitsch 1984) - a concept that forms the basis of
eradication programmes for BHV1 (Ackermann and others 1990a).
Furthermore, as pointed out by Kennedy (1973) and Nettleton (1986) it
also means that recovery of virus does not constitute proof of
primary infection.
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REACTIVATION OF LATENT INFECTION
The demonstration by Sheffey and Rodman (1973) that experimentally
infected, clinically recovered cattle reexcreted BHV1 after several
days administration of high doses of corticosteroid (40 mgs
dexamethasone) was a major advance in the understanding of BHV1
latency. It provided scope for numerous further experimental
reactivation studies in which reexcretion from the respiratory or
genital tracts was demonstrated following natural infection or live
virus vaccination (Darcel and Darwood 1975, Nettleton and Sharp 1980,
Pastoret and others 1984).
The amount of virus excreted at reactivation is much less than during
primary infection but appears to have unaltered biological and
molecular properties (Rodriquez and others 1984, Pastoret and others
1984) although there may be some genome variability (Whetstone and
others 1989). Narita and others (1981) described degenerative
changes in the trigeminal ganglia following each of two
dexamethasone-induced recrudescences three months apart and concluded
that cattle can excrete virus several times during their lives.
Miller and others (1987) similarly used dexamethasone to demonstrate
the presence of BHV1 in the ovary of latently infected cattle thereby
indicating that embryonic death could develop following reactivation.
Reactivation of latent virus may cause reexposure to antigen leading
to an increase in humoral antibody, which partly explains the
long-term persistence of BHV1 titres in infected cattle (Bitsch 1973,
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Kahrs 1977). Pastoret and others (1984) suggested that sufficiently
immunised animals can control their rate of virus reexcretion and
dissemination and that reactivation may serve as a booster to the
immune system. Despite this, Straub (1990a) noted that
corticosteroid treatment of latently infected cattle did not
necessarily produce an increase in SNT titre. The mechanism of
dexamethasone-induced BHV1 reactivation is not known. It appears
that immunosuppression itself is not directly responsible (Davies and
Carmichael 1973) and that dexamethasone may have a direct effect on
virus-neuron interaction (Rock and others 1992).
Naturally occurring events associated with viral reactivation are
poorly understood although it is generally accepted that it occurs as
the result of increases in endogenous corticosteroids following
stress factors such as transport, parturition, intercurrent disease,
dehorning, castration and overcrowding (Nettleton and Sharp 1980, Guy
and Potgieter 1985, Rock and others 1992). Thiry and others (1987)
stimulated reactivation experimentally using transportation as did
Msolla and others (1983) by challenging latently infected bullocks
with lungworm larvae; Mensik and others (1986) achieved the same
effect with PI3 virus. Espinasse and others (1983) reactivated
I
latent BHV1 using intrarum0nal 3-methylindole, shown previously by
Carlson and others (1975) to be the causal agent of fog fever.
Edwards and Roeder (1983) failed to reactivate latent BHV1 in calves
with experimental immunosuppression by ruminant pestiviruses.
Parturition was shown by Thiry and others (1985) to induce BHV1
reactivation but they considered it was a rare event and suggested
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that the stress of labour rather than the physiological status itself
was responsible (Thiry and others 1984).
There are reports in the literature (Gibbs and Rweyemamu 1977) of
clinical recrudescence at the time of reactivation although this is
not usually as severe as expected with primary infection (Kahrs 1977)
and is generally considered to be insignificant (Straub 1990a),
albeit subject to specific immune status (Pastoret and others 1984,
Ludwig 1984). However, a watery or mucopurulent nasal discharge,
conjunctivitis and ulceration of the nares and laryngeal mucosa have
been described following corticosteroid-induced reactivation (Davies
and Carmichael 1973, Davies and Duncan 1974, Narita and others 1981)
and Msolla and others (1983) described typical signs and lesions of
IBR in latently infected bullocks subjected to a heavy challenge with
lungworm larvae. Observations from the field (Hyland and others
1973, Van Nieuwstadt and Verhoeff 1983, Corkish and Richards 1983)
have revealed mild apparently recrudescent clinical disease in closed
endemically infected breeding herds, the sources being attributable
to reactivation of latent infection (Kahrs 1977). Donkersgoed and
Babiuk (1991) similarly remarked that IBR seen in feedlot calves that
had been on the unit for some time was the result of reactivation and
transmission of virus from latently infected pen mates.
TRANSMISSION AND CIRCULATION
Many authors have observed that IBR outbreaks are usually preceded by
the recent introduction of new cattle into a herd (Gibbs and
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Rweyemamu 1977, Wiseman and others 1980, Blood and Radostits 1989a).
Karge (1989) considered that BHV1 is mainly transmitted from herd to
herd and imported into disease-free countries by latently infected
cattle - a view shared by most other authors. Cattle that have
become infected without showing clinical signs and which are still
shedding virus (up to 10 - 16 days following experimental infection
according to Straub 1991) and those with mild clinical signs that are
attributed to factors such as transportation stress, are other
potential sources of infection (Straub 1990a), as are calves born
alive after surviving late gestational infection (Pospisil and others
1979). Spread of infection from live virus vaccinates to susceptible
close contacts has also been reported (McKercher and Crenshaw 1971,
Zygraich and others 1974) although it may be fairly limited in extent
(Baker and others 1989).
Non-bovine mammalian species such as rabbits (Lupton and others
1980), skunks and hamsters (Straub 1990a) can be experimentally
infected with BHV1. Serum neutralising antibodies to BHV1 have been
found in a variety of ruminant species, although there is
considerable cross-reactivity with other antigenically related
herpesviruses including those of cervidae and caprines (Nixon and
others 1988). The virus has also been isolated from the soft shelled
tick Ornithodorus coriaceus (Taylor and others 1982). The role of
these various species as carriers or reservoir hosts is unclear
although Straub (1990b) listed direct or indirect contact with
virus-shedding wild animals as a possible source of BHV1 infection
for cattle. Collings and others (1972) speculated about the
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possibility of BHV1 being transmitted by the stable fly (Stomoxvs
calcitrans) but Johnson and others (1991) found no experimental
evidence to indicate that it occurred with the face fly (Musca
autumnal isl. Whilst aerosol transmission is undoubtedly important
over short distances, particularly under intensive housing conditions
(Elazhary and Darbyshire 1979, Yates 1982) there are no reports of
the long distance airborne spread seen with ADV (Gloster and
others 1984).
It has long been accepted that semen from bulls actively or latently
infected with BHV1 provides an important potential source of
infection either through natural service (Huck and others 1971) or
via AI (Drew and others 1987). This led to the adoption of strict
control measures on AI studs (Lucas 1986). Despite such precautions,
BHV1 was still introduced into a herd in Switzerland by imported
semen (Kupferschmied and others 1986). Straub (1990a) examined the
possible role of embryo-transfer (ET) in the transmission of BHV1 and
concluded that no danger existed: although the virus adheres to the
zona pellucida it is readily removed by washing and trypsin treatment
(Singh and others 1983, Stringfellow and others 1990).
It has been proposed (Gibbs and Rweyemamu 1977) that virus
perpetuation results from an interplay between short cycles of acute
disease with high levels of virus excretion and the prolonged
reexcretion of reactivated latent virus. Calf rearing and fattening
units appear to play an important part in the maintenance of BHV1 by
virtue of the regular introduction of young susceptible calves from
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heterogenous herds of origin and extensive opportunities for stress
induced reactivation and close contact. The onset of new cases in
susceptible populations can be gradual, particularly in large herds
being continually replenished and where cow-to-cow contact is minimal
(Kahrs 1977). Ferris and others (1964) observed that new cases
continued to occur for 10 to 20 days in herds of less than 100 cattle
kept in close contact. In what appears to be the only detailed
long-term study of BHV1 circulation in infected herds reported in the
literature, Van Nieuwstadt and Verhoeff (1983) found r.o serological
evidence of virus circulation for at least three years in eight of
19 infected dairy herds in Holland.
ANTIBODY PREVALENCE SURVEYS
Numerous surveys have been carried out to examine the prevalence of
BHV1 antibody as an indicator of natural exposure or vaccination in
the cattle population. The findings from 35 such surveys performed
worldwide since 1975 were summarised by Straub (1990a): 14 of the 15
largest surveys (>1000 sera) showed antibody prevalences of between
about one and 37 per cent.
In Britain, Dawson and Darbyshire (1964) examined 2000 sera collected
from abattoirs and suspected cases of mucosal disease and found 2.1
per cent contained BHV1 antibodies. They recorded serological
evidence of infection in 16 of 42 counties in England and Wales. In
1974, Kirby and others (1978) found that 6.8 per cent of 2,368 sera
submitted to Reading Veterinary Investigation Centre (VIC) for
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brucellosis testing from herds in Buckinghamshire, Berkshire and
Oxfordshire, were seropositive for BHV1. Subsequent surveys in
Britain demonstrated increasing antibody prevalences: Peters and
Perry (1983) found 11.4 per cent reactors in young pedigree beef
bulls held at two Meat and Livestock Commission bull performance
testing centres between 1979 and 1981; Msolla and others (1981)
e
recorded a seroprev^nce of 12.1 per cent from a large survey of dairy
herds in Scotland.
Edwards (1988) undertook a retrospective analysis of serological data
held at the CVL for the period 1970 to 1986. He reported that BHV1
seroprevalence amongst healthy cattle tested for export or entry into
AI centres increased from less than five per cent in the early 1970s
to 10 - 12 per cent by the mid-1980s; the proportion of seropositive
diagnostic submissions increased from 9.1 per cent in 1969 - 1974 to
34.7 per cent for 1984 - 1986. In a more recent survey, Hogg (1992)
found a seroprevalence of 32.4 per cent amongst cattle aged four to
12 months in 503 herds in Britain with a history of respiratory
disease.
Detailed information on age-specific prevalence patterns for BHV1
infection is generally lacking from the literature. However, Kirby
and others (1978) noted a higher proportion of seropositive cattle in
older age groups (^five years) compared with those aged two years or
less and Forschner (1988) also commented that seroprevalence
increased with age. Msolla and others (1981) found more reactors
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amongst dairy cows than heifers in Strathclyde but not in the
Grampian region of Scotland.
Forschner (1988) noted that fewer than 20 per cent of animals were
infected in more than 70 per cent of diseased herds in Germany. In
their serological study in Spain, Espuna and others (1988) found that
seroprevalence exceeded 30 per cent in 87 per cent of infected herds
although 46 per cent of herds contained no reactors. Edwards (1988)
reported that 48 per cent of herds in England and Wales contained at
least one seroreactor.
CONTROL AND ERADICATION
Within the European community (EC) IBR is classified in Group 3
(except on AI and ET units where it is subject to mandatory control
as a Group 2 disease) (Prince 1990). Category 3 comprises endemic
diseases intended to be controlled by voluntary attestation
programmes which member states should aim to harmonise with each
other (Gibson 1991). Although potent vaccines are available to
prevent economic losses from IBR, their widespread adoption in
countries such as the USA has caused problems with the export of live
cattle, semen and embryos to parts of the world demanding
BHVl-seronegative status (Wyler and others 1989, Straub 1990b).
Despite potential drawbacks suggested by Kahrs (1977), elimination of
BHV1 infection from herds or regions presents a viable alternative to
vaccination (Bradley 1985, Blood and Radostits 1989a). Bitsch (1985)
commented that attempts to eliminate BHV1 should have a good chance
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of success if infected animals can be separated from uninfected
cattle and precautions taken to prevent indirect transmission.
There are a few detailed reports in the literature of successful
schemes for eliminating BHV1 infaction from individual herds. Bitsch
(1984) and Bradley (1985), both working with heavily infected beef
suckler herds, built-up uninfected populations by rearing
seronegative calves separately from reactors. Corkish (1988)
similarly divided an infected suckler herd into seropositive and
seronegative groups: purchases were required to be seronegative for
BHV1 when tested after a month in isolation, before being allowed
into the negative group. Bradley (1985) observed that calves born to
cows previously infected with virulent BHV1 became seronegative
following maternal passive antibody decay and if kept isolated could
preserve their eligibility for entry into AI studs or for export.
Ackermann and others (1990b) failed to stop BHV1 transmission by
preventing direct contact between seropositive and seronegative
groups of calves on a large fattening unit although they
subsequently eliminated the infection when separation was improved
(including the use of a plastic curtain) and stricter hygiene
measures were adopted to prevent indirect contact.
In addition to control methods based on segregation of reactors and
testing of replacements, there has been much interest in the last
five or six years, particularly in Germany, in the use of inactivated
vaccines to boost the immunity of latently infected carriers to
reduce their viral excretion and thereby prevent spread to uninfected
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herd members. According to Forschner (1988) virus shedding is
suppressed if humoral antibody titres can be maintained at a high
level by repeated vaccination (usually at six monthly intervals).
This approach is considered to be of particular value in herds where
slaughter of all reactors would be prohibitively expensive
(Wittkowski 1990).
In the initial trials in a large herd of bulls, Meyer and others
(1985) reported increased serological titres for four to five months
after vaccination and a significantly reduced duration of virus
excretion following immunosuppressive stress. In subsequent field
trials in Germany performed over more than three years, Forschner and
others (1987) claimed that BHV1 infection ceased to spread in 36 of
38 herds following primary immunisation and repeated revaccination of
reactors. Gossger (1988) reported similar findings in a smaller
study over an 18 month period and questioned the optimum time
interval between revaccinations in relation to cost. Although the
strategic use of inactivated BHV1 vaccine is now widely adopted in
Germany (particularly Bavaria), Gibson and Edwards (1991) found very
little scientific evidence to confirm that vaccination actually
suppressed virus shedding and recent experiments by Straub (1991)
have shown no correlation between humoral antibody titres and virus
shedding which casts doubt on conclusions from earlier studies.
In Switzerland (Ackermann and others 1990c) and Denmark (Report
1985), IBR has been made compulsorily notifiable and successful
eradication programmes based on slaughter of seropositive animals,
-26-
with compensation, have resulted in the virtual elimination of BHV1
infection from their national herds (Ackermann and others 1990c,
Edwards 1991). Elsewhere in Europe, BHV1 infection is variously
managed using combined vaccination/eradication programmes depending
on disease significance and governmental strategy (Wyler and others
1989). Straub (1991) made a distinction between "eradication"
(freedom from BHV1 in the whole cattle population of a country or
state without using vaccine) and "sanitation" (elimination of BHV1
from a herd or group of organised breeders using vaccine if
appropriate).
Well developed voluntary programmes in both France and Germany rely
on an initial bulk milk ELISA test to detect infected dairy herds,
combined with individual blood testing to identify seroreactors
(Gibson and Edwards 1991). Inactivated vaccine, as discussed above,
is used when reactors are retained: in Germany, reactors only are
vaccinated but in France the entire age cohort containing reactors is
vaccinated. In these countries herds containing only a few
seropositive cattle can achieve BHVl-negative status following a
series of herd blood tests, with removal of reactors, combined with
control measures to prevent reinfection. A similar scheme
(Agricultural Development and Advisory Service [ADAS] 1987) was
introduced into Britain in 1987 (Penton 1987) and is featured in this
study.
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CHAPTER 2: THE STUDY AREA AND ITS CATTLE POPULATION
The underlying reference population applicable throughout this
dissertation comprised cattle herds maintained in the county of
Norfolk, England, within the period 1980 - 1991. In view of its
numerically small size, in an area dominated by arable farming, this
account of cattle production in Norfolk was considered essential to
allow the findings to be seen in context with the rest of the British
cattle industry.
GENERAL CONSIDERATIONS
Norfolk (Fig 2.1) is bounded by the Wash and the Cambridgeshire Fens
to the west and the North Sea to the north and east; it is separated
from Suffolk to the south by the River Waveney (Fig 2.2). The
adjoining counties of Norfolk and Suffolk constitute the region of
Britain known as East Anglia.
Although basically flat, the Norfolk landscape gently undulates up to
300 feet above sea level. It is a county of low average annual
rainfall and extremes of ambient temperature; the topography,
climatic conditions and abundance of high quality agricultural land
have favoured arable production (Fig 2.3) for centuries (Ministry of
Agriculture, Fisheries and Food [MAFF] 1981a).
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Fig 2.1: Map of Norfolk showing county boundaries, principal rivers,
towns and sub-regions.
(Adapted from MAFF 1981a)
Poultry and pigs dominate livestock farming: over 30 per cent of
turkey production and eight per cent of pig production in England and
Wales is based in Norfolk (MAFF 1990a). Although the sheep
population is less than 0.5 per cent of the total for England and
Wales (MAFF 1990a), numbers continue to increase and there are now
several very large flocks in the Breckland area (Fig 2.1).
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Fig 2.2 : Aerial photograph of the Waveney valley grazing area of
Norfolk
(By courtesy of the Aerial Photography Unit, MAFF Cambridge)
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Fig 2.3 : Distribution of main agricultural enterprises in Norfolk
(By courtesy of ADAS, Norwich)
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Fig 2.4 : Cattle grazing marshland near Great Yarmouth, Norfolk
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SEASONAL MARSHLAND GRAZING
Seasonal marshland grazing (Fig 2.4), mainly centred around
Broadland (Fig 2.1), is an integral part of traditional cattle
farming practice in the region. Broadland is a popular holiday area
which extends into north-east Suffolk; it contains tidal rivers,
river valleys and broads (shallow lakes originating from 15th century
peat diggings). Most of the farmed area of Broadland is permanent
pasture maintained at, or below, sea level by a drainage system which
pumps water up from a series of dykes into the rivers.
Marshland graziers can be broadly divided into two categories (Report
1987). The first of these, the owner-occupiers, usually with dairy
herds, are mainly located up the river valleys towards the source.
Their marshes tend to be more secluded and have less potential
contact with other herds than elsewhere. Further down the valleys,
most grassland is rented as annual grazing lets of between about 10
and 30 acres, traditionally sold by annual public auction in the
spring and available for use only until the end of October of each
year.
Although cattle are separated by dykes, several metres wide, for many
herds the marshes represent a significant potential source for
acquiring new infections (Pritchard and others 1989). About 400
different (mainly local) cattle producers (including dealers)
regularly used rented marshes during the 1980's to supplement home
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grazing, particularly for replacement dairy heifers, dry cows and
cross-bred beef calves (G A Pritchard, personal communication).
There was an increasing trend to introduce sheep onto the marshes as
the decade progressed.
CATTLE PRODUCTION
Despite its relatively small size, the cattle industry in Norfolk is
important aid highly efficient. In June 1989, the total cattle
population of Norfolk was 112,615 which represented 1.3 per cent of
the total number of cattle in England and Wales (MAFF 1990a). This
compared with 150,250 cattle in June 1980, which was 1.6 per cent of
the England and Wales total (MAFF 1981b).
Dairy herds
The dairy industry in Norfolk has steadily declined since the 1960s
accelerated by beef conversion schemes, the introduction of milk
quota and increased cereal production. In 1989, the number of dairy
producers registered under the Milk and Dairies (General) Regulations
1959, fell to 249 herds compared with 311 in 1985 and 409 in 1980.
Despite this decline, dairying remained the major grass utilising
enterprise in Norfolk during the 1980s, based mainly on unploughable
pasture in low lying areas such as the Waveney valley of south
Norfolk (Fig 2.2).
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Whilst the total number of dairy cows in the county fell during the
decade, herd structure did not change significantly (Table 2.1).
About 20 per cent of herds contained less than 10 cows (mainly
house-cows) and over 50 per cent of herds contained more than 50
cows. The average size of registered dairy herds in 1989 was about
100 cows. The majority of dairy herds were in long established large
mixed enterprises; the remainder were mostly small family-owned
farms. Hoistein/Friesian was by far the predominant breed; most
herds claimed pedigree status.




















































% E&W total : Percentage of total cattle population of England and
Wales.
(Adapted from Agricultural Census returns: MAFF 1981b, 1986, 1990a)
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Breeding was invariably by AI, often supplemented with a "sweeper"
bull; the more progressive herds utilised ET to increase the genetic
potential of their best cows. Herds calved mainly during the autumn.
Winter housing was generally in strawed yards although many herds
also used cubicles. Supplementary and winter feeding was based
mainly on arable by-products, particularly sugar beet tops, brewers
grain and straw, fed in conjunction with grass silage.
There was generally little or no contact between the adult milking
herd and calves reared as breeding replacements. After removal from
their dams soon after birth, calves were usually housed separately
from the main herd during the winter and spent two years on marsh
and, or, sheltered upland grazing before returning to their parent
herds to calve at between two and three years of age.
Disease security precautions adopted on most dairy farms were minimal
although large blocks of arable land (Fig 2.2) invariably separated
herds and prevented direct contact (apart from at communal marshland
grazing).
Suckler herds
Total beef suckler cow numbers remained fairly static during the
1980s (Table 2.2) but there was a slight upturn towards the end of
the decade attributable to the introduction of the Environmentally
Sensitive Areas (The Broads) Designation Order 1986, which offered
financial incentives to encourage traditional livestock grazing on
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the marshes, and the introduction of the High Mowthorpe system of
suckled calf production (ADAS 1988) which proved to be well suited to
the rough grazing areas of Norfolk (G Thwaites, personal
communication).
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% E & W total : Percentage of total cattle population of England and
Wales.
(Adapted from Agricultural Census returns: MAFF 1981b, 1986, 1990a)
Suckler herds were largely established on farms with some permanent
grassland, and arable by-products and home grown fodder available for
winter feeding. A variety of different husbandry and management
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practices were adopted and many herds were small part-time
enterprises. The preferred period for calving was between November
and April but some herds calved virtually all the year round.
Most herds were solely commercial, based on Hereford X Friesian or
Limousin X Friesian cows, with Charolais, Limousin or Simmental
bulls. These produced cross-bred calves for finishing on cereals.
An estimated 20 per cent of suckler herds were either entirely
pedigree or included a small pedigree herd managed alongside the
commercial herd. Although a few indigenous breeds were represented,
the majority of pedigree herds were made up of continental
breeds. There was increasing interest during the decade in the
importation of more exotic breeds such as Piedmontese or Salers;
owners frequently used ET to capitalise on the high prices available
for the calves.
Precautions against the introduction of disease in suckler herds were
invariably poor although they were improved by the presence of large
expanses of arable land and long approach roads. Disease security in
commercial suckler herds was particularly bad because they usually
replaced some 20 - 25 per cent of cows each year with heifers
obtained from a variety of sources of unknown disease status
(Pritchard and Bardsley 1990). In pedigree herds using ET,
recipients were often purchased from markets, thereby further
increasing the risk of disease introduction.
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Calf rearing and fattening herds
Most surplus calves born to local dairy and suckler herds remained in
the county. Some breeders reared their own surplus calves to 10 - 14
weeks of age for subsequent sale to barley beef units; others
fattened them through to finishing weight.
Several farming companies and cooperatives ran contract rearing and
fattening schemes. These collected calves for local redistribution or
obtained calves (via dealers) from outside the area, particularly
from the West Country. The numbers of calf rearing units in Norfolk
fluctuated widely depending on cost of concentrate feed, the export
market and viability of alternative enterprises. Precise information
on the size of the industry was not available from census returns.
Most rearing units averaged about 50-60 calf places and reared three
batches of calves a year, often as a part-time business using a wide
variety of husbandry and feeding systems.
Because of concern regarding infectious diseases, such as
salmonellosis, hygiene measures were often better than in breeding
herds. However, since more than 60 per cent of calves came from
outside the county (E Randall, personal communication), calf rearers
remained continually at risk of introducing new disease.
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CHAPTER 3; CLINICAL DISEASE OUTBREAKS
IBR was first convincingly recorded in Norfolk during the winter of
1979 when four separate outbreaks were confirmed by Norwich VIC
amongst recent imports of fattening cattle into the county from store
markets. This was during a period of increased disease surveillance
by the Veterinary Investigation Service (VIS) and heightened
awareness by veterinary practitioners and cattle producers. The
subsequent occurrence and main clinical and epidemiological features
of confirmed outbreaks of IBR in Norfolk during the 1980s are
reviewed in this chapter.
MATERIALS AND METHODS
Sources of data
During the period covered by this study the author was engaged as a
veterinary investigation officer at Norwich VIC with a particular
responsibility for ruminant diseases. Norwich VIC was established in
1958 as part of a national network of veterinary laboratories
operated by the State Veterinary Service (SVS). Amongst its
activities, the Centre provided a diagnostic and advisory service for
practising veterinary surgeons in Norfolk and maintained local
surveillance of disease trends in farmed livestock with particular
reference to new and emerging conditions. The data used for the




Using standard laboratory questionnaire forms (Appendix 3.1),
veterinary practitioners submitted a variety of specimens from cattle
herds in Norfolk to the VIC for diagnostic tests for IBR. In
addition to the identity of the affected herd, these submission forms
included details of the age and clinical history of the stock
involved.
On-farm investigations
Some IBR incidents, particularly those of an unusual or complex
nature, were investigated on the farm by the author in conjunction
with the owner's veterinary surgeon. Specimens collected at these
farm visits were submitted to the VIC for appropriate examinations.
Detailed reports were prepared.
Telephone consultations
Veterinary practitioners frequently sought telephone consultations to
discuss IBR outbreaks. Details were usually recorded and these
provided an important, albeit anecdotal source of intelligence data




Under the Brucellosis (England and Wales) Order 1981 (as amended),
cattle owners were required to notify the Divisional Veterinary
Officer of all abortions that took place less than 271 days after
insemination. Specimens from the aborted cow, including a clotted
blood sample, were submitted to the VIC by the farmer's veterinary
surgeon to test for Brucella abortus, accompanied by a report form
(Appendix 3.2) which provided identification details, age and breed.
Practitioners frequently requested further tests, including
serological examinations for BHV1, to be undertaken as part of the
differential diagnosis to establish the cause of the abortion.
Farm-file records
Detailed records of disease history were maintained in individual
herd files kept at the VIC. These included records of telephone
consultations and results of all diagnostic tests, including
statutory abortion submissions and formed a convenient source of data
for measuring the occurrence of IBR and the serological status of
individual herds.
Monthly Disease Reports
An internal report was prepared at the VIC giving brief clinical and
epidemiological details relating to the main diagnoses achieved each
month. These reports, which also provided the basic information for
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the account of VIS activities featured in the Veterinary Record,
contributed a useful recorded summary of local disease trends during
the study period.
Veterinary Investigation Diagnosis Analysis II
Specimens received at VICs provided the basis of a computerised
diagnostic data bank known as Veterinary Investigation Diagnosis
Analysis II (VIDA II) (Hall and others 1980). IBR was not
specifically recorded by VIDA II until 1980 when confirmed incidents
were listed either under group 1 "Systemic diseases of cattle and
those not readily classified organically" (code 213) or under group 9
"Diseases of the reproductive and mammary system of cattle" (code
039) which included fetopathies attributed to BHV1 infection. Repeat
diagnoses on further specimens from the same incident were excluded.
Laboratory diagnosis
Techniques employed
Diagnostic procedures used during these studies followed standard
methods adopted by the VIS (MAFF 1984). It was outwith the scope of
this dissertation to provide a detailed account of virological
techniques employed in the laboratory to confirm BHV1 infection:
these procedures will therefore be described in outline only.
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Virus isolation was undertaken routinely at Norwich VIC between 1980
and 1986, using primary bovine monolayer culture (kidney or testis)
supplied by the Virology Department of the CVL. After 1986, as part
of a rationalisation programme, samples were sent to other VICs for
virus isolation. A fluorescent antibody test (FAT) developed at the
CVL (Edwards and others 1983) was used at Norwich VIC after 1980 to
detect BHV1 antigen in nasal, naso-pharyngeal or conjunctival swabs
or lung tissue. The detection of Cowdry type A intranuclear
inclusion bodies in bronchial or alveolar epithelium (Jubb and others
1985) was occasionally used for disease confirmation until 1982 but
this histological approach was discontinued once virus isolation and
FAT techniques were fully established in routine use.
Sera from clotted blood samples were dispatched to other VICs or the
CVL to test for BHV1 antibodies. Between 1980 and 1982, most sera
were examined with the IHAT (Kirby and others 1974). This test was
subsequently discontinued by the VIS in favour of the one hour serum
neutralisation test (SNT) (Frerichs and others 1982) which was used
routinely for diagnostic submissions until 1985. The more sensitive
24 hour SNT was occasionally used as a decisive test for samples with
an apparently low antibody level (Edwards and others 1986). After
1985, the SNT was largely superseded for routine diagnostic use by a
simpler ELISA technique (Edwards and others 1986). In accordance
with standard guidelines used in the VIS, antibody titres for BHV1 of
>1/8 with the IHAT were considered "positive" as were titres of >.1/2
with the SNT and optical densities (ODs) of >0.1 with ELISA.
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Specimen collection
The choice of diagnostic material rested with veterinary
practitioners. They were requested to provide fresh specimens
(ocular, nasal or naso-pharyngeal swabs, viscera or carcases) from
recent cases for virological examinations or to submit "paired" blood
samples (taken at the acute and convalescent stage of infection, two
to four weeks apart) if serological diagnosis was required. For the
FAT they were advised preferably to use naso-pharyngeal
swabs - either long guarded "brush" swabs (Thomas and Stott 1975)
supplied by the CVL or human laryngeal swabs (Medical Wire Company)
for sampling, depending on the age of animal, and to submit the swabs
to the VIC in VTM (Tryptose phosphate broth with antibiotics) if
possible.
Criteria for laboratory confirmation
Apart from the occasional use of histology for laboratory
confirmation in 1980/81, a diagnosis of IBR was reached only if BHV1
was isolated in tissue culture or detected by FAT in specimens
submitted from suspected clinical cases, or if seroconversion (a
change in titre from negative to positive) or a significant increase
in titre (four-fold increase in SNT or IHAT titre or an increase in
0D of >,0.2 with the ELISA) was demonstrated with paired samples.
BHV1 fetopathy was confirmed by virus isolation in primary cell
cultures using pooled fresh fetal tissue or with paired serology from
aborting dams (Pritchard 1990). A positive antibody titre or 0D
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value for BHV1 was taken to indicate either exposure to field
infection, vaccination or, in the case of calves up to about six or
seven months old (Kahrs 1977, Bitsch 1984) the possible presence of
MDA. High titres for BHV1 can be maintained for long periods of time
(Chow 1972, Bitsch 1984): single serological titres were therefore
not used for disease diagnosis because they did not provide any
reliable information concerning the timing of the incident.
Single-sample serology was however, widely used for antibody
screening purposes, as described in subsequent chapters.
Extraction, collation and analysis of data
The terms "incident" and "outbreak" were used synonymously to
describe an identified occurrence of disease involving one or more
animals (Thrusfield 1986a). Details of confirmed IBR incidents in
Norfolk between January 1980 and December 1989 were obtained from a
systematic manual search of farm-file archives, monthly reports and
records of on-farm investigations and telephone consultations. The
main clinical and epidemiological features of each incident were
recorded using a card-index system.
Using the approach adopted by VIDA II, outbreaks were broadly
classified as either systemic disease or fetopathy. Systemic
outbreaks in breeding herds were further subdivided on the basis of
clinical history (supplemented if necessary by further consultation
with the veterinary surgeon involved) into either epidemic disease
with high morbidity in fully susceptible herds or clinically mild low
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morbidity recrudescences (Gibbs and Rweyemamu 1977, Kahrs 1977).
The findings were tabulated according to date of incident (month/year
of commencement or of laboratory submission if not known), herd
identity, herd type (dairy, beef suckler, or "fattener" ie calf
rearing/fattening unit), age of affected stock and clinical
definition of the incident (epidemic, recrudescence, fetopathy).
Monthly disease occurrence was compared with VIDA II data (MAFF
1990b) supplied by the Epidemiology Unit, CVL. Reasons for any
discrepancies between archival data and VIDA II were noted where
possible. Laboratory methods used to confirm IBR outbreaks were
recorded by year to show trends in diagnostic methodology.
RESULTS
Laboratory diagnosis
Although practitioners were advised on the suitability of specimens
for IBR diagnosis, the quality of material submitted to the
laboratory depended on numerous factors: the client, the stage and
severity of outbreaks, potential economic losses, expertise and
experience of the practitioner, availability of sampling equipment
and distance from the laboratory. Submissions came from more than
300 different herds and varied from a single nasal swab or clotted
blood sample to several pieces of fresh or decomposing viscera or
entire carcases. Some swabs had clearly been left for several days
to dry out in the veterinary surgeon's car; others were almost
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completely lacking in mucosal epithelial cells because of poor
sampling technique.
Eighty-three systemic I BR incidents were recorded in Norfolk between
1980 and 1989. Most were confirmed either by paired serology (39.8
per cent) or the FAT alone (32.4 per cent). Table 3.1 shows the
clear trend away from virus isolation in tissue culture to the FAT as
the method of choice for virus detection in systemic outbreaks. All
thirteen fetopathy incidents were confirmed by paired serology; virus
isolation was attempted on viscera from more than 100 fetuses without
success.
TABLE 3.1 : Methods of laboratory confirmation of systemic incidents
Method of confirmation
No of Virus FAT + r«j Paired
Year Outbreaks Iso1ation Virus on y Serology Histolo9^uuioreaK
Qnly isolation only ierolo9y
1980 8 4 0 0 3 1
1981 12 2 5 0 3 2
1982 3 1 0 2 0 0
1983 5 2 1 1 1 0
1984 8 0 3 3 2 0
1985 11 1 1 6 3 0
1986 7 0 0 4 3 0
1987 7 0 0 3 4 0
1988 16 0 0 6 10 0
1989 6 0 0 2 4 0
Totals 83 10 10 27 33 3
% 100.0 12.1 12.1 32.4 39.8 3.6
*Discontinued after 1982
Serological diagnosis was requested mainly for abortion
investigations and systemic outbreaks (particularly after 1985) in
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which there was no significant respiratory component (eg during
suspected recrudescences) to merit the collection of nasal or ocular
swabs, and to ascertain whether BHV1 infection was involved in
multifactorial calf pneumonia outbreaks. Second (convalescent) blood
samples were received from less than 10 per cent of incidents for
which serological diagnosis was sought.
Disease occurrence
Outbreaks of systemic IBR were confirmed every year, with peaks in
1981, 1985 and 1988; the lowest incidence (three outbreaks) was in
1982. As shown in Table 3.2, there was a fairly close match between
the VIC archival data and VIDA II. When it occurred, over-recording
on VIDA II could usually be attributed either to inadvertently
counting rediagnoses as new incidents or basing diagnoses on
inadequate criteria. Under-recording was associated mainly with a
failure to register all confirmed incidents or not recording them
until several weeks after their commencement (in which case they
usually appeared in the next month's entry). In two of the 13
confirmed fetopathy incidents (Table 3.3) abortions occurred during
systemic outbreaks. The under-recording of fetopathies by VIDA II
when compared with the farm-file records, was almost entirely due to
inadequate recording and failure correctly to match up results from
paired serology.
As shown in Table 3.4, most outbreaks (44.6 per cent) occurred in
dairy herds, closely followed by fattening herds (41.0 per cent). In
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dairy herds, systemic IBR was confirmed every year except 1982. Nine
of the 13 recorded fetopathies were in dairy herds; none were
confirmed before 1984. There was a regular pattern of disease
occurrence in fattening herds with between two and five outbreaks
confirmed each year. Excluding rediagnoses of separate incidents in
subsequent years, new outbreaks of clinical IBR (including fetopathy)
were confirmed in 35 different dairy herds, 14 suckler herds and on
30 fattening units during the study period.
Table 3.5 shows the monthly occurrence of all confirmed systemic
incidents and fetopathies according to herd type. Outbreaks on
fattening units occurred almost entirely during the late autumn and
winter, between the months of October and March, whereas outbreaks in
breeding herds (amongst adult cattle) were seen throughout the year.
Overall, 40 (48.2 per cent) of the 83 systemic outbreaks were in
adult cattle compared with 22 (26.5 per cent) amongst calves aged up
to six months (these included six incidents in breeding herds). Ten
outbreaks (12.0 per cent), all in fattening herds, occurred amongst
cattle aged six to 12 months and 11 (13.3 per cent) involved cattle
aged between one and two years. Seven of the latter outbreaks were
in fattening cattle.
Clinical and epidemiological features
Most outbreaks in fattening herds were associated with a history of
recent purchases, particularly from markets. A few outbreaks on
larger units appeared to result from immunologically naive calves
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becoming infected from direct or indirect (aerosol) contact with
older calves that had recovered from clinical disease and were
sharing the same airspace. The clinical features of typical IBR
outbreaks in beef fattening cattle have been described extensively in
the literature and will not be considered in any detail here. They
varied in severity from mild conjunctivitis (Fig 3.1) and watery
nasal discharge to severe fatal disease with necrotising tracheitis
(Fig 3.2). After 1984, practitioners sometimes commented that
clinical features suggestive of mild IBR were present during
multifactorial calf pneumonia outbreaks but it was rarely possible to
substantiate these claims to any extent. Coexistent infection with
BVDV was confirmed in IBR outbreaks on two fattening units.
Epidemic outbreaks in breeding herds generally had a clear history of
the recent introduction of purchased replacement breeding stock -
usually from outside East Anglia. In some incidents, the
added-animals themselves exhibited clinical signs soon after their
arrival, but more usually, outbreaks commenced about two or three
weeks later amongst in-contact cattle in the resident herd. In
breeding herds the disease followed the typical course described in
the literature: the case history of one such outbreak investigated by
the author is presented as an addendum to this chapter. Considerably
fewer outbreaks were confirmed in suckler herds than dairy herds
(Table 3.6) and they tended to be of less economic significance. Six
outbreaks in breeding herds were apparently restricted to calves but
insufficient information was available to establish the degree of
contact with the main herds. Even during severe epidemic outbreaks,
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Fig 3.2: Necrotising tracheitis with thick diphtheritic
exudate due to IBR
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there were no confirmed accounts of the disease spreading from the
milking herd into the calf house but there were several reports from
the field of IBR spreading to calves grazing alongside infected
suckler cows. Four outbreaks occurred amongst maiden or bulling
heifers which were being kept on grazing completely separate from the
adult herd. Concurrent parasitic bronchitis was confirmed during IBR
outbreaks in three dairy herds and one suckler herd.






Suckler herds All herds %
Epidemic disease
in adult cattle
17 9 26 41.9
Epidemic disease




5 1 6 9.7
Recrudescence
in adult cattle 13 0 13 21.0
Fetopathy 9 4 13 21.0
Totals 46 16 62 100
* Aged 12 - 24 months **^six months old
Thirteen (35.1 per cent) of the 37 systemic outbreaks in dairy herds
were classified as recrudescences (Table 3.6). These invariably
occurred in herds known to have a high prevalence of seropositive
cattle based on farm-file data (see Chapter 4) or a past history of
IBR. They generally involved less than five per cent of cattle in
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the herd - often only one or two younger cows were affected.
Clinical signs were usually mild and comprised slight pyrexia,
inappetence and a fall in milk yield for two or three days; a slight
watery oculonasal discharge was often present. Unlike epidemic
outbreaks, recrudescences were not usually preceded by the purchase
of breeding replacements althougn homebred heifers entering
endemically infected adult herds sometimes developed mild clinical
signs. Recrudescence was not confirmed in suckler herds.
All fetopathies involved single abortions apart from incidents in two
herds in which two and three abortions were confirmed during periods
of about two weeks. Abortions were occasionally reported by
practitioners during suspected epidemic outbreaks but, except in two
incidents, all confirmed fetopathies occurred in herds with no
history of overt clinical disease, although there was usually
evidence to suggest that they were endemicaly infected. One of the
two exceptions was in a dairy herd in which two cows aborted two
weeks after the commencement of a typical epidemic outbreak; the
other incident occurred during recrudescence amongst a group of
second and third parity cows.
DISCUSSION
Despite the well known shortcomings (Martin and others 1987a) of
using laboratory data, particularly the biased voluntary submissions
to VICs (Thrusfield 1988), to monitor disease occurrence, it was
probable that submissions to Norwich VIC for IBR diagnosis provided
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an accurate reflection of the situation in the field. The
introduction of improved diagnostic tests and efficacious vaccines
during the early 1980s motivated veterinary practitioners to seek
laboratory confirmation for suspected outbreaks. Virtually all
diagnostic testing for IBR in England was undertaken within the
V1S/CVL (Anon 1979) which further improved the effectiveness of
disease surveillance.
Although the sources of information were essentially the same, the
data collected from Norwich <JIC archives provided a more accurate and
comprehensive account of disease occurrence than VIDA II. Not only
were original reports re-examined and diagnostic criteria
standardised but the type of herd involved and the form of the
outbreak were also considered. Despite these refinements, the close
correlation with VIDA II data was reassuring in view of the numerous
opportunities for operator error and potential for diagnostic
inconsistencies inherent in the recording system. By using the 1985
census data for breeding herds with more than 10 animals (Table 2.1)
as a guide to mean population size during the study period, it was
evident that about 11 per cent of dairy herds and five per cent of
suckler herds in Norfolk experienced confirmed IBR during the
10 years under investigation.
As pointed out by Nettleton (1986), the submission of inadequate
material to the laboratory adversely affects the diagnostic success
rate for IBR. This undoubtedly reduced the number of confirmed
outbreaks recorded during these studies although probably not to any
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great extent, because practitioners often subsequently submitted
further, more suitable samples, from the same incident. Virus
isolation in cell culture is the most sensitive method of diagnosing
BHV1 infection but it suffers inherent drawbacks, including a
possible delay of up to 14 days before achieving a diagnosis
(Nettleton 1986). With veterinary practitioners constantly under
pressure from clients seeking a rapid diagnosis, it was not
surprising that the FAT evolved as the main method of confirming IBR
outbreaks. Kahrs (1977) and Nettleton (1986) both advised that
seroconversion to BHV1 should be demonstrated in addition to virus
detection, in order to distinguish between primary infection and
virus reactivation. Such an approach was impractical in most field
situations and despite the number of outbreaks confirmed by serology,
practitioners were generally reluctant to submit paired blood
samples. Although not used for disease diagnosis, testing single
serum samples from convalescent animals often proved useful in
excluding BHV1 infection from the differential diagnosis,
particularly with fetopathies.
The FAT was not used to diagnose BHV1 abortions because of its low
efficacy with fetal tissue (Lucas and others 1986). Similarly, fetal
fluid serology was not used to diagnose BHV1 abortion because it is
generally considered (Kendrick 1973, Lucas and others 1986) that the
virus causes fetal death before antibody can be produced. Despite
this, Murray (1990) used the latter method to apparently confirm BHV1
abortion in fetuses from Cumbria examined between 1984 and 1986.
Focal necrotic lesions, which are reported to occur in cases of BHV1
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infection (Owen and others 1964) were not seen in any of the fetuses
examined. Virus isolation in tissue culture is potentially the best
method of confirming BHV1 abortion (Stubbings and Cameron 1981), but
this proved completely unsuccessful during these studies. Because of
the delay between BHV1 infection and abortion (Pritchard 1990),
seroconversion has almost invariably occurred before paired blood
samples can be collected. Consequently, a rise in antibody titre or
seroconversion are rarely demonstrable. Despite these problems,
paired serology was the only method whereby BHV1 fetopathy was
confirmed during these studies although the possibility that the
stress of abortion reactived latent virus (Thiry and others 1985)
leading to a coincidental increase in antibody titre could not be
discounted. The actual number of recorded BHV1 abortions undoubtedly
underestimated the field situation because of difficulties with
diagnosis. However, there was no noticeable increase in the number
of statutory abortion submissions from recently infected herds and no
evidence from anecdotal sources to suggest that BHV1 was a
significant cause of abortion in Norfolk herds. These observations
supported the conclusions of other authors in Britain, including
Edwards (1988).
The term "recrudescence" has been used somewhat loosely in the
literature to describe recurrent infection associated with
reactivation and excretion of latent virus (Gibbs and Rweyemamu 1977,
Kahrs 1977, Narita and others 1981, Straub 1991) although Russell and
Edington (1986) reserved its use for excretion associated with fresh
lesions, as with herpes "cold sores" in man. Naturally occurring IBR
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recrudescence has received little attention in the past and most
authors appear to be of the opinion that it is clinically
insignificant. These present studies would dispute that view and
suggest that not only can recrudescence cause some economic loss,
particularly by reducing milk yield, but it is also a sure indication
of continuing virus circulation and active infection. The
significance of this in relation to programmes for the elimination of
BHV1 from infected herds is discussed later in this thesis.
It was not possible to determine conclusively whether recrudescences
at a herd level occurred predominantly amongst animals experiencing
virus reactivation or amongst naive in-contacts, but the fact that
second and third parity cows appeared to be the most commonly
affected group suggested that the latter was usually the case. This
was borne out by findings detailed in Chapter 5. The clinical
recognition of recrudescence was somewhat haphazard, being
particularly dependent on alert stockmanship, especially if only a
few animals were involved in the outbreak. The number of
recrudescences recorded here was inevitably a gross underestimate of
the extent of recrudescence in the field.
Whereas epidemic IBR outbreaks were almost invariably associated with
the recent introduction of new stock, there were no such obvious
external sources of infection with outbreaks classified as
recrudescences. This observation, also made by Kahrs (1977)
supported the hypothesis that these incidents were endogenous in
origin. Significantly, herds experiencing recrudescence were
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invariably known or suspected to be carrying a heavy weight of
endemic infection.
Although IBR was prevalent amongst calves on fattening and rearing
units, relatively few outbreaks were confirmed in young calves in
breeding herds. Wiseman and others (1980) similarly noted that IBR
did not appear to spread significantly from the adult cows to calves
on the same farm. Wiseman and others (1980) also commented that
cattle kept outside experienced clinically less severe IBR outbreaks
than housed cattle. This could explain why fewer outbreaks were
reported in suckler herds than in dairy herds. Furthermore, mild
outbreaks, particularly recrudescences, were more likely to pass
unnoticed in suckler herds because herdsmen had less contact with
their cattle. Nevertheless, the low incidence of IBR recorded in
suckler herds was still surprising because they ran a greater risk of
introducing infection with purchased replacement breeding stock
(Pritchard and Bardsley 1990) than dairy herds, which mainly bred
their own replacements.
The present findings generally supported the observations of Wiseman
and others (1980) and Edwards (1988) regarding the occurrence of most
IBR outbreaks during the winter housing period. However, it was
clear from these studies that systemic outbreaks in adult breeding
cattle occurred throughout the year whereas outbreaks in calves on
rearing and fattening units invariably occurred during the winter.
The winter pattern for calf outbreaks was probably due to the same
causes as those predisposing to enzootic calf pneumonia including
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cold, dampness and poor ventilation (Blood and Radostits 1989b).
There was no clear explanation for the all-year-round occurrence of
outbreaks in adult cattle but it may have been associated with a
tendency to introduce purchased (ie possibly infected) replacement
breeding heifers during the summer months.
Whilst IBR outbreaks occurred sporadically in Norfolk throughout the
1980s, there were no reports of the genital forms of BHV1 infection
(IPV/IPB). After a period of great concern for the cattle breeding
industry during the early 1970s, these conditions now appear to have
been virtually, if not completely, eliminated from Britain (Edwards
1983, Edwards 1988, Edwards, personal communication) with the
introduction of strict control measures at AI Centres (Lucas 1986).
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ADDENDUM : CASE HISTORY OF AN IBR OUTBREAK IN A DAIRY HERD
Herd details
This was an established 100-cow family-run dairy herd in an isolated
location. Cows were winter-housed in strawed yards on a conventional
ration of silage, sugar-beet pulp and concentrates. Breeding was by
artificial insemination to calve July - September; a "sweeper" bull
was used on the heifers. Male calves were sold soon after birth;
female calves were retained as heifer replacements, initially kept in
the calf house adjacent to the cows but moved to a separate farm
after weaning where they remained until returning to the main herd to
calve at about two years of age. The herd had been virtually closed
until 12 cows purchased from a dispersal sale in the Midlands were
delivered by a dealer in three separate loads between 20/10/84 and
6/11/84.
History
On 8/12/84, five purchased cattle developed pyrexia of 103 - 107°F
(39.5 - 42.0°C), inappetence, a watery ocul^t<-nasal discharge and
showed a fall in milk yield (Table 3.7). The affected cows were
injected with broad-spectrum antibiotic by the farmer but by the next
day four homebred cows were also affected. By 11/12/84, a total of
27 cows from the 80 cows then in the milking herd were showing
similar clinical signs. Eighteen cows were considered by the owner's
veterinary surgeon to be sufficiently ill to merit a three day course
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of antibiotic therapy. There were no fatalities or abortions during
or after the outbreak and clinical signs were not seen amongst any
cattle apart from those in the milking herd.
Diagnosis
To confirm the outbreak, three conjunctival swabs and three
naso-pharyngeal "brush" swabs were taken from recently affected cows
and put into VTM. At the VIC, a good positive result for IBR was
obtained with the FAT carried out on the naso-pharyngeal swabs but
there were insufficent cells from the conjunctival swabs to provide a
definitive result. The FAT results were subsequently confirmed by
virus isolation in tissue culture.
Vaccination
The entire milking herd (including clinical cases) was vaccinated
with "Tracherine" (Smithkline Animal Health Ltd) on 13/12/84. No
fresh cases were seen in the herd within three days after vaccination
and milk yield soon returned to normal (Table 3.7). Heifers that
joined the milking herd in July 1985 were vaccinated but there was no
subsequent revaccination of the milking herd.
Economic losses
The cost of the outbreak was summarised by the farmer as: £550 for
veterinary expenses (including vaccination), £150 for milk discarded
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due to antibiotic usage (1000 litres @ 15p/litre) and £510 for loss
in potential milk yield due to illness (3400 litres @ 15p/l). The
total cost of the outbreak was therefore estimated at £1310
(approximately £16 per lactating cow).
Table 3.7: Effect of IBR outbreak on herd milk yield
Date (Dec 1984) Expected
Milk yield (1itres)
Actual Shortfall
2 - 8 11,500 11,457 43
9 - 15 12,000 8,373* 3,627
16 - 22 12,700 11,978 722
23 - 29 13,500 13,493 7
Totals (2 - 29) 49,700 45,301 4,399
* Including milk discarded due to antibiotic treatment
Recrudescence
After the initial IBR outbreak had resolved, sporadic recrudescences
with pyrexia, milk drop and mild respiratory signs, were confirmed by
paired serology between 1986 and 1988. These mainly affected a few
second and third parity cows and suggested that BHV1 was still
circulating in the herd. This was further confirmed by serological
tests in 1988, after which a programme was set up to eliminate the
infection (see D24, Chapter 6).
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CHAPTER 4 : SERO-EPIDEMIOLOGICAL OBSERVATIONS
Despite numerous serological surveys, there is a lack of information
in the literature about the distribution of BHV1 infection in
different types of herd and age-specific prevalence patterns. The
studies described in this chapter utilise the results of tests for
BHV1 antibodies performed on sera submitted to Norwich VIC to examine
these aspects in some detail and to provide general background
information on the BHV1 serological status of Norfolk herds.
MATERIALS AND METHODS
Extraction and collation of data
Details of all sera from cattle in Norfolk herds tested for BHV1
antibodies (by IHAT, SNT or ELISA) between 1980 and 1989 were
obtained by manually searching farm-file records as described in the
previous chapter. The serological results were recorded as negative
or positive; they included findings from statutory brucellosis
abortion submissions (for which differential diagnosis had been
sought) and those from systemically diseased or apparently diseased
cattle. Where paired sera were submitted, only the results from the
second samples were included. The results of tests on healthy cattle
examined for disease screening purposes were also recorded. Single
laboratory submissions of more than 20 sera from the same herd were
excluded as were the results of tests carried out specifically for
Cattle Health Scheme membership (see Chapter 5).
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The information provided by veterinary practitioners on the
appropriate laboratory submission forms (Appendices 3.1, 3.2) was
used to extract the following data : year of submission, herd
identity and type, age (if given), number of sera tested, number of
positive sera (reactors) and submission category (reason for
testing). The latter were classified as either: fetopathy
investigation (including infertility), diagnosis of systemic illness
(i.e. respiratory disease, milk-drop or other non-specific, usually
febrile illness) or health screening tests undertaken prior to sale,
purchase or export. Other criteria including seropositive thresholds
were as described in the previous chapter.
Analysis of data
The number and proportion of sera containing BHV1 antibodies were
calculated according to year, herd, age and submission category. The
results were tabulated to show annual trends and combined to provide
period prevalence. Individual herds were classified as infected if
one or more sera were positive, based on the assumption that most
cattle with humoral antibodies were latently infected and therefore
potential sources of infection to other members of the herd (Kahrs
1977).
The proportion of possibly uninfected breeding herds was estimated
(Cannon and Roe 1986) from the period prevalence data in those herds
for which 10 or more sera had been tested without detecting a
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reactor, assuming average (1985) herd sizes listed in Tables 2.1 and
2.2 and an expected 25 per cent of positives. Such herds in which at
least 50 per cent of sera tested were positive were identified as
likely to be heavily infected.
Statistical tests were calculated at the five per cent level of
significance unless stated otherwise. Differences in antibody
prevalence between submission categories were compared using the
chi-square test (Dunn 1967). The 95 per cent confidence intervals
(CI) for the proportion of potentially uninfected, infected, and
heavily infected breeding herds and for the prevalence of reactors
according to year, submission category, herd type and age, were
calculated for sample size n and estimated prevalence P using the
formula (Snedecor and Cochran 1967):
RESULTS
Annual trends and submission categories
The wide annual variation in the number of sera submitted for testing
(Table 4.1) appeared mainly to reflect changes in the disease
surveillance and charging policies of the VIS. During the period
1980 - 1982, sera submitted for disease diagnosis were not normally
examined unless a second sample was subsequently received. About 50
per cent of sera examined were from statutory abortion
investigations. Most sera from cases of systemic illness tested
n 2 n
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between 1980 and 1985 related to respiratory disease. After 1985,
tests were more frequently carried out as part of investigations into
causes of milk-drop or non-specific febrile illness, as these
features of recrudescent BHV1 infection became more widely
appreciated. There was an increased interest by farmers in disease
screening tests in 1988 and 1989 following the introduction of the
Cattle Health Scheme (see Chapter 5).
A total of 1908 sera from 274 herds (158 dairy, 89 suckler
27 fattener) were tested for BHV1 antibodies: 510 (26.7 per cent)
were positive. Of the 537 sera from systemically affected animals,
175 (32.6 per cent) were positive; this was not significantly
different to the proportion of positives (28.2 per cent) from
fetopathies. A significantly smaller proportion of sera (15.0 per
cent) from healthy cattle contained BHV1 antibodies than either of
the two diseased categories (chi-square = 37.6, Pc.001). None of the
76 sera (from eight different herds) tested for export and included
in Table 4.1 were positive although the majority of export blood
samples were sent direct to the CVL and results were not all
available to the author.
Type of herd
The overall proportion of sera containing BHV1 antibodies was
greatest in fattening herds (Table 4.2) but there were no
statistically significant differences in antibody prevalence between
the three herd types.
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Year No + % No + % No + %
1980 16 12 75.0 NT NT NT 8 4 50.0
1981 61 22 36.1 NT NT NT 9 4 44.4
1982 47 14 29.8 27 8 29.6 15 2 13.3
1983 65 13 20.0 9 0 0.0 7 1 14.3
1984 186 44 23.7 20 16 80.0 2 2 100.0
1985 67 12 17.9 22 2 9.1 6 1 16.7
1986 224 68 30.3 50 17 34.0 18 1 5.6
1987 122 23 18.9 39 17 43.6 13 9 69.2
1988 278 70 25.2 53 20 37.7 17 7 41.2
1989 388 102 26.3 129 27 20.9 10 2 20.0
Totals 1454 380 26.1 349 97 27.8 105 33 31.4
95% C I 23, 00 1 ro 00 .4 23.0 - 32 .6 22..1 - 40.8
No Number of sera tested
NT No sera tested
+ % Number and percentage of sera containing BHV1 antibodies
95% C I 95 per cent confidence intervals
The 1454 dairy herd sera contributed more than 75 per cent of all
samples examined; one or more reactors were found in 76 (48.1 per
cent) of these 158 herds. This provided 95 per cent CI of 40.0 to
56.2 per cent for the minimum proportion of infected dairy herds in
the sample population. No reactors were detected in 13 (26.5 per
cent) of 49 different dairy herds from which at least 10 sera were
submitted. This gave 95 per cent CI of 13.1 to 39.9 per cent for the
proportion of potentially uninfected herds. Similarly, in 17 (34.7
per cent) of the 49 herds (95 per cent CI 20.3 to 49.1 per cent) at
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least half the sera tested were positive, suggesting that these were
heavily infected herds. These included herds with recrudescent
outbreaks as mentioned in the previous chapter.
Reactors were found in 31 (34.8 per cent) of the 89 different suckler
herds (95 per cent CI 24.4 to 43.5 per cent) and 15 (55.6 per cent)
of the 27 fattening units (95 per cent CI 36.8 to 74.4 per cent),
neither of which was significantly different to the proportion of
infected dairy herds. No reactors were found in four of 11 different
suckler herds contributing 10 or more sera; at least half the sera
tested were positive in five herds.
Age-related effects
Ages were available for 1208 (83.1 per cent) of the sera from dairy
herds, 314 (90.0 per cent) of sera from suckler herds and for all
fattening herd sera. There were no significant differences in the
proportion of reactors in sera from cattle for which age was provided
compared with sera from all cattle tested.
Table 4.3 shows the age-related prevalence of BHV1 antibodies by herd
type using the combined data from 1980 - 1989. The proportion of
positive sera from calves aged up to six months in dairy herds was
less than in either fattening or suckler herds. However, since the
samples were derived from a relatively small number of herds,
statistical comparisons were inappropriate. Antibody prevalence fell
to its lowest level at between six and 12 months of age in all three
herd types but subsequently increased in yearlings. The mean
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Noumberofseratestedwithagprovid d +%Numberandpercentageofserco tainingBHV1ntibod es 95%CI5percentonfidenceintervals
seroprevalence then remained virtually unchanged (at about 20 per
cent) until three years, after which it increased with age to peak at
nearly 40 per cent in seven-year-old cattle. As shown by the 95 per
cent CI given in Table 4.3 antibody prevalence in seven-year-old
cattle was significantly greater than in those aged six months to
three years.
DISCUSSION
Although inevitably derived from a biased sample the serological data
analysed here represented a sizeable proportion of the Norfolk cattle
population - the 170 dairy herds comprised 54.3 per cent of the 313
herds containing at least 10 cows as listed in the 1985 agricultural
census returns (Table 2.1). In their survey, Dawson and Darbyshire
(1964) found no evidence of BHV1 infection in Norfolk but the number
of sera tested was not stated. The prevalence (29.7 per cent) of
BHV1 antibodies in the 1521 sera (Table 4.1) submitted for disease
diagnosis (ie excluding screening tests on healthy cattle) between
1980 and 1989 was slightly, although probably not significantly, less
than the 34.7 per cent recorded by Edwards (1988) in a much larger
survey of diagnostic sera tested at the CVL from herds in England and
Wales.
The findings demonstrated that BHV1 infection was more widespread in
Norfolk than suggested by the number of confirmed outbreaks of IBR
described in the previous chapter. Brenner and others (1989)
similarly remarked on the disparity between BHV1 seroprevalence from
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surveys and reports of clinical cases of IBR. The introduction of
the ELISA test after 1985 improved diagnostic sensitivity over the
standard SNT and IHAT tests (Edwards and others 1986) but it seemed
unlikely that any resultant increase in the number of reactors
detected from low titre sera significantly affected the findings
reported here.
Period prevalence is generally of limited epidemiological value as a
measure of disease occurrence because it fails to distinguish between
new and old cases (Thrusfield 1986b). However, because BHV1 titres
persist and seropositive animals constitute a continuing source of
infection (Kahrs 1977), period prevalence was still considered to
provide a useful guide to assessing the proportion of herds and
individual cattle in the study population that had experienced BHV1
infection and were therefore still potentially infective.
The significantly lower proportion of reactors amongst healthy cattle
supported the findings of Peters and Perry (1983) and Edwards (1988).
It should be noted, however, that these surveys of apparently healthy
cattle mainly involved testing sera from young bulls or heifers prior
to export or AI. Such cattle would be expected to show a lower
antibody prevalence than apparently diseased cattle of various ages
because they were in a consistently younger age group. The
age-related effect of BHV1 infection questions the validity of using
such sources of data as the basis of estimates of antibody prevalence
amongst clinically normal cattle. The most reliable estimate of
antibody prevalence in breeding herds, particularly dairy herds, came
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from the abortion sera. These indicated that between 25.3 and
31.0 per cent of adult cattle in Norfolk were seropositive for BHV1.
Unlike systemically diseased animals, aborting cows represented a
clearly defined population of mature cattle; furthermore, since
abortion was not a significant sequel to BHV1 infection (Chapter 3),
their sera provided a relatively unbiased sample of the normal cattle
population.
Edwards (1988) reported that 48 per cent of herds in England and
Wales tested between 1984 and 1986 contained one or more reactors.
This was very similar to the total of 122 (44.5 per cent) from 274
different herds (including fattening units) in Norfolk which
contained at least one reactor. However, Edwards (1988) classified
each batch of sera submitted as a different herd which probably
underestimated the true proportion of infected herds. Also, more
significantly, his findings were based on herds examined during a
three year period instead of the 10 years of the present study.
The prevalence of BHV1 antibodies in sera from fattening calves was
greater (although not significantly) than in dairy herds but attempts
to draw any conclusions from this were hampered by the different
population turnover rates and sources of origin of calves in these
two types of herds, the small number of fattening sera tested and the
effects of MDA. Nevertheless, since most calves on fattening units
came from outwith the county, the higher antibody prevalence amongst
this group further suggested that BHV1 infection was more prevalent
outside Norfolk than in indigenous herds.
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The low antibody prevalence in cattle aged between six and 12 months
in all three herd types supported the findings described in the
previous chapter which showed that the incidence of clinical disease
was also fairly low amongst this age group. The fall in antibody
prevalence was also likely to be associated with the decline in MDA
after about six months of age. The subsequent increase in prevalence
of BHV1 antibodies amongst yearling cattle (mainly breeding heifers
reared apart from the main herd) suggested that some of these became
infected before rejoining their parent herds for calving. This may
have occurred whilst grazing communal marshland but it also possibly
reflected the serological status of heifers purchased as breeding
replacements from outside the area.
The age-related prevalence data for older cattle was derived mainly
from individual cows and represented a large number of herds
surveyed. It showed a statistically significant increase in the
proportion of cattle with BHV1 antibodies between three and seven
years of age. Since most herds calved at between two and
three-years-old the findings suggested a constant probability of
acquiring infection after calving with increasing age. This was
consistent with horizontal spread of an endemic infection (Martin and
others 1987b) and supported reports by other authors (Kirby and
others 1978, Msolla and others 1981, Forschner 1988) that BHV1
seroprevalence increased with age.
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CHAPTER 5: EPIDEMIOLOGICAL STUDIES IN CATTLE HEALTH SCHEME HERDS
The concept of BHV1 latency dictates that after recovering from acute
infection, cattle probably remain a potential source of virus for
life. Although many studies have shown that reactivation and
shedding of latent virus can be induced experimentally, the extent to
which this occurs naturally under field conditions, leading to new
infection, is not known. The cross-sectional studies described here
utilise the results of whole-herd serological screening tests
undertaken in breeding herds in Norfolk to examine the epidemiology
of subclinical BHV1 infection with particular reference to the
transmission of virus from serological reactors to uninfected herd
members.
MATERIALS AND METHODS
Cattle Health Scheme herds
In April 1987, the SVS introduced the Cattle Health Scheme (CHS) for
Great Britain (Penton 1987, ADAS 1987). This superseded the Enzootic
Bovine Leukosis (EBL) Attested Herd Scheme (Roberts and Bushnell
1982) and also offered an IBR monitoring programme which gave farmers
the opportunity to carry out serological testing for BHV1 and to
eliminate the infection from their herds where appropriate.
Sixty-three breeding herds in Norfolk joined the CHS to become EBL
attested during the four year period between March 1987 and
-80-
March 1991. A standard questionnaire (Appendix 5.1) was completed at
the initial visit to each farm, at which the author was accompanied
by the owner's veterinary surgeon. Details recorded included: herd
size (number of cattle aged two years or more), herd type (dairy or
beef suckler), breed, status (pedigree or non-pedigree/commercial),
replacement policy (main sources and numbers purchased during the
previous 10 years), general management practices and disease history.
Owners were encouraged to have some, or all, of their cattle examined
for serological evidence of BHV1 infection when they were tested for
EBL (by their veterinary surgeon or by a MAFF Animal Health Officer),
provided the herd had no recent clinical history of IBR (or IPV/IPB)
or IBR vaccination (which would have made it virtually impossible to
interpret serological findings). Seven herds were thereby excluded
from the investigations: in three the owners declined to undertake
any serological testing for BHV1 and four had a history of IBR and
had been vaccinated during the previous two years. One dairy herd
that had experienced epidemic IBR in 1981 and been vaccinated with
"Tracherine" (SmithKline Animal Health Limited) was included because
there was no history of revaccination or clinical recrudescence.
None of the remaining 55 herds had any apparent history of IBR
although 25 had contributed serological data, including some
seropositive samples, to the analysis for 1980 - 89 presented in the
previous chapter.
The 23 dairy herds in the study population had all been established
for at least 20 years and were of pedigree status (20 herds were
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Holstein/Friesian and three were Ayrshire), Most of the 33 suckler
herds had been assembled during the previous 10 years and all but one
contained solely or predominantly pedigree cattle. The main suckler
breeds represented were: Simmental (10 herds), Charolais
(four herds), Blonde d'Aquitaine (four herds), Limousin (three
herds), Salers (two herds), and one herd each of: Aberdeen Angus,
South Devon, Bazardais, Longhorn, British White, Murray Grey,
Highland, Belgian Blue, Shorthorn and Hereford. The systems of
husbandry and management were essentially as described in Chapter 2,
but being high quality pedigrae herds, the sale of breeding stock and
regular exhibition at agricultural shows featured prominently in most
enterprises.
Serological testing
All cattle, including calves, were blood sampled in 22 herds
(10 dairy, 12 suckler): the actual number of calves sampled in these
herds depended on the time of year of the test in relation to the
calving pattern. Adult cattle only (:>two years) were tested in 31
herds (10 dairy, 21 suckler) and in four dairy herds testing was
limited to a sufficient number of adult cattle to detect a 10 per
cent level of reactors with a 95 per cent confidence (Cannon and Roe
1982).
An ELISA technique (Edwards and others 1986) performed at Penrith
VIC, was used to examine CHS sera for BHV1 antibodies. When the
scheme was first introduced, cattle were deemed seropositive
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("reactors") at 00 values of >0.1 using a serum dilution of 1/50, but
an inconclusive reactor (IR) category (0D 0.10 - 0.19), which
required resampling, was subsequently introduced by the SVS in April
1989 to cope with some inconsistent results. In 1990, the 24 hour
SNT (Edwards and others 1986) was routinely adopted at the CVL as the
decisive test for IRs that could not be clarified by ELISA: SNT
titres of >1/2 were classed as positive. Reagent concentrations for
use by the VIS for CHS tests were altered in October 1989 resulting
in a change in the 0D range for IRs to 0.15 - 0.25, although the
sensitivity of the ELISA test remained the same.
Collation and analysis of data
The 0D values for each animal tested were expressed as either
seropositive or seronegative and recorded with their ear tag or
freeze brand number, sex, age, source (homebred or purchased) and any
individual pre-purchase vaccination history (if known).
Herds were coded D (Dairy) or S (Suckler) and numbered sequentially
according to the date of the blood test. The serological results
were tabulated and also displayed graphically to show the
distribution of BHV1 antibodies according to herd identity, herd type
(D or S), age and whether cattle were homebred or purchased. Herds
were classified according to antibody prevalence and the apparent
rate of seroconversion amongst susceptible cattle.
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Results were analysed using standard statistical methods (Dunn 1967);
mean values, standard deviations (SD) and standard errors (SE) were
calculated where appropriate. Differences in antibody prevalence
between dairy and suckler herds were compared using the chi-square
test. Correlation coefficients (r) were used to examine the
association between the number of reactors and: herd size, number of
cattle purchased in the previous 10 years and number of purchased
cattle currently in the herd. The association between reactors and
purchase was further examined by fitting a generalised linear model
(binomial error, logit link) with Genstat. 5 (1987), the linear
predictor consisting of terms herd and homebred/purchase.
After the test results were known, herd managers were contacted by
telephone to discuss the significance of the findings. In herds with
a low seroprevalence, details of the movement history (eg communal
marsh grazing, attendance at agricultural shows and temporary
residence in other herds) of individual reactors and the length of
time they had been in the herd were recorded. Where seropositive
calves up to nine month old were known to have sucked seropositive
dams, they were assumed to have acquired MDA. This was slightly
later than the seven months duration of MDA suggested by Bitsch




Antibody prevalence according to type and size of herd
Sera from a total of 4,219 cattle (3,201 dairy, 1,018 suckler) aged
>two years were examined for BHV1 antibodies: 639 (15.1 per cent)
were positive. Herd sizes and the number and proportion of reactors
in dairy and suckler herds are shown in Tables 5.1 and 5.2. The
proportion (14.6 per cent) of reactors in dairy cattle was not
significantly different to the proportion (16.8 per cent) of reactors
amongst sucklers (chi-square = 2.84, p>0.5). There was a significant
correlation (r=0.05, p<.05) between the number of reactors and herd
size in suckler herds but not in dairy herds.
There were no reactors in five (21.7 per cent) of the 23 dairy herds
and 11 (33.3 per cent) of the 33 suckler herds (chi-square = 0.90,
p>.05). Of the remaining dairy herds, 14 held 20 per cent or fewer
reactors but the other four (D3, D16, D20, D21) each contained more
than 60 per cent reactors. Fifteen suckler herds contained 20 per
cent or fewer reactors; only one suckler herd (S27) had a
seroprevalence of more than 60 per cent but in two others (S19, S20)
it exceeded 40 per cent. The frequency distribution for the
proportion of reactors in all herds is summarised in Fig 5.1.
-85-
Table 5.1 : Prevalence of BHV1 reactors in dairy herds
Herd Month/Year Cattle aged ^2 yearsof test No + %
D1 3/87 227 0 0
D2 3/87 *60 ( 95) 5 8.3
D3 4/87 136 97 71.3
D4 5/87 *26 (136) 5 19.2
D5 10/87 254 14 5.5
D6 10/87 189 0 0
D7 1/88 133 18 13.5
D8 4/88 154 6 3.9
D9 7/88 123 6 4.9
D10 11/88 114 0 0
Dll 5/89 117 1 0.9
D12 11/89 *30 (161) 0 0
■D13 12/89 117 12 10.3
D14 1/90 140 2 1.4
D15 3/90 176 7 4.0
D16 3/90 *28 (200) 25 89.3
D17 3/90 260 19 7.3
D18 5/90 121 7 5.8
D19 9/90 52 0 0
D20 2/91 134 84 62.6
D21 2/91 147 92 62.5
D22 2/91 196 39 19.9
D23 3/91 267 29 10.9
Totals 3/87 - 3/91 3201 468 14.6
No Number of cattle tested for BHV1 antibodies
+ Number of reactors
% Percentage of reactors
* Statistical screening only
(total number of cattle years in herd)
■ IBR in 1981
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SI 7/87 24 2 8.3
S2 2/88 10 0 0
S3 2/88 18 1 5.5
S4 2/88 90 3 3.3
S5 3/88 55 5 10.7
S6 4/88 7 1 14.3
S7 11/88 16 1 6.3
S8 12/88 60 4 6.7
S9 1/89 20 0 0
S10 2/89 29 4 13.8
Sll 5/89 25 0 0
S12 5/89 56 11 19.6
S13 7/89 25 2 8.3
S14 7/89 4 0 0
S15 7/89 5 0 0
S16 11/89 9 0 0
S17 12/89 27 6 22.2
S18 1/90 86 4 4.7
S19 2/90 76 42 55.3
S20 4/90 125 55 44.0
S21 5/90 18 0 0
S22 5/90 6 0 0
S23 9/90 10 3 30.0
S24 10/90 25 0 0
S25 11/90 12 0 0
S25 11/90 8 2 25.0
S27 11/90 16 10 62.5
S28 12/90 40 0 0
S29 12/90 13 5 38.5
S30 12/90 10 2 20.0
S31 12/90 22 2 9.1
S32 1/91 35 4 11.4
S33 1/91 35 1 2.9
Totals 7/87-1/91 1018 171 16.8
No
+
Number of cattle tested
Number of reactors
for BHV1 antibodies





70 80 90 100
% Reactors in each herd
Frequency distribution of BHV1 reactors in CHS herds
Antibody prevalence according to source of origin
Breeding replacements were purchased from a wide geographical area,
mainly outside Norfolk, extending from Scotland to the West Country
and continental Europe. Only three herds (D1,D6,D9) had been
completely closed during the previous 10 years (Tables 5.3, 5.4),
with the mean number of cattle purchased being 17.1 + SD 17.5 in
dairy herds and 22.7 ± SD 22.5 in suckler herds. The mean number of
purchased cattle in dairy herds at the time of the test (7.2 ± SD
8.4) was less than half that in suckler herds (15.9 + SD 20.1) but
the latter included several recently established herds (notably S27,
which had been formed a year previously from cattle purchased
exclusively from S19).
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Table 5.3 : Prevalence of BHV1 reactors in dairy herds according to
source
Purchased Cattle Homebred Cattle
Herd No in No in No of No in No of
10 years herd Reactors Herd Reactors
D1 0 0 0 227 0
*D2 25 5 3 55 2
D3 24 16 15 120 82
*D4 30 2 1 24 4
D5 2 2 1 252 13
D6 0 0 0 189 0
D7 60 34 7 99 11
D8 58 20 6 134 0
D9 0 0 0 123 6
D10 21 14 0 100 0
Dll 10 10 1 107 0
*D12 6 4 0 26 0
D13 8 8 4 100 8
D14 8 8 1 132 1
D15 40 16 5 160 2
*D16 32 9 9 19 16
D17 2 1 1 259 18
D18 10 2 1 119 6
D19 10 0 0 52 0
D20 3 1 0 133 84
D21 25 4 4 143 88
D22 10 9 5 187 34
D23 9 0 0 267 29
Total 393 165 64 3036 404
* Statistical screening only
No in 10 years: Total number of cattle purchased
in the previous 10 years
No in herd : Total number of purchased cattle in the herd
and included in the test
Significant correlations were noted in suckler herds, but not in
dairy herds, between the number of reactors and the number of cattle
purchased in the previous 10 years (r= 0.42 p<.05) and between the
number of reactors and the number of purchased cattle in the herd at
the time of the test (r= 0.63, p<.01). In dairy herds, the mean
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Table 5.4 : Prevalence of BHV1 reactors in suckler herds according
to source
Purchased Cattle Homebred Cattle
Herd No in No in No of No in No of
10 years herd Reactors Herd Reactors
SI 20 12 2 12 0
S2 3 1 0 9 0
S3 18 3 1 15 0
S4 8 3 2 87 1
S5 30 23 4 33 2
S6 5 5 1 2 0
S7 36 6 1 10 0
S8 25 18 4 42 0
S9 6 6 0 14 0
S10 27 27 4 2 0
Sll 8 4 0 21 0
S12 54 54 10 2 1
S13 25 25 2 0 0
S14 4 4 0 0 0
S15 3 3 0 2 0
S16 4 4 0 5 0
S17 24 12 6 15 0
S18 94 86 4 0 0
S19 65 47 21 29 21
S20 45 68 26 57 29
S21 18 18 0 0 0
S22 12 6 0 0 0
S23 4 4 2 6 1
S24 6 1 0 24 0
S25 4 3 0 9 0
S26 8 8 2 0 0
S27 16 16 10 0 0
S28 30 9 0 31 0
S29 13 13 5 0 0
S30 4 4 2 6 0
S31 70 4 2 18 0
S32 10 8 4 27 0
S33 50 20 0 15 1
Totals 749 525 115 493 56
No in 10 years: Total number of
in the previous




purchased cattle in the herd
the test
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percentage of purchased reactors (41.3 + SE 3.2) was significantly
greater than that of homebred reactors (17.6 + SE 0.7) (pc.OOl). In
suckler herds this difference was less marked (13.9 + SE 1.5, 9.9 +
SE 1.4 respectively) but still statistically significant (p<.05).
In two dairy herds (D8, Dll) and 14 suckler herds (SI, S3, S6, S7,
S8, S10, S13, S17, S26, S27, S29, S30, S31, S32) all reactors had
been purchased; some comprised the original foundation stock, still
in the herd after seven (S30) or eight (S6) years. Many of the
purchased reactors in suckler herds, but not in dairy herds, were ET
recipients known to have been vaccinated before introduction.
Details of the vaccination history and sources of individual reactors
are listed according to age in Tables 5.5 and 5.6.
Antibody prevalence according to age
All reactors detected amongst calves up to six months old (Tables 5.5
and 5.6) and the single reactor aged nine months in D5 had received
colostrum from known seropositive dams, with the exception of the
reactor in S9 which was from a dam of unknown BHV1 status having been
purchased from a local market at two months of age. Single reactors
were present amongst cattle less than two years old in three herds
(D10, S9, S11) in which all older cattle were seronegative. Those in
S9 and Sll were both purchases and that in D10 was a homebred heifer
known to have broken in with a group of cattle of unknown disease
status whilst grazing communal marshland about a month before the
test.
-91-
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As shown in Tables 5.7 and 5.8 the mean antibody prevalence in dairy
and stickler herds calculated from pooled data declined from about six
per cent in calves aged up to six months to virtually nil (only one
reactor from 220 calves) by 12 months. Seroprevalence amongst
yearlings, two-year-olds and three-year-olds was markedly lower in
dairy herds than in suckler herds but since most of the latter
reactors were limited to a few herds (particularly S19), statistical
comparisons between herd types were considered inappropriate. From
four years of age, mean seroprevalence increased at a similar rate in
both types of herd and by 10 years nearly 47 per cent of all cattle
were reactors, including all eight (in herds D21,D22,S17,S30 and S32)
that were 15 years or older (Tables 5.5 and 5.5).
Seroconversion patterns
As illustrated by the pooled data presented in Figs 5.2 and 5.3 the
age-specific prevalence for individual herds revealed two distinct
patterns of seroconversion which corresponded to the main antibody
prevalence groupings noted earlier. In the four dairy herds (D3,
D16, D20, D21) with a high prevalence (HP) of BHV1 antibodies (>60
per cent) seroconversion appeared to commence amongst heifers within
two or three months after they joined the main herd for calving;
uncalved heifers on separate grazing were all seronegative apart from
the single yearling reactor in D3 which appeared to have acquired
infection through contact with a yearling steer from another herd.




Fig. 5.2 - Seroconversion patterns in dairy herds according to
antibody prevalence category
Age in years
Fig. 5.3 - Seroconversion patterns in stickler herds according to
antibody prevalence category
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In the 14 dairy herds with a low prevalence (LP) of BHV1 antibodies
(<20 per cent) there was no such evidence of active infection amongst
heifers after calving and less than five per cent of cows in their
second or third parity were seropositive. These included purchased
cattle that may have seroconverted before entry into their new herds.
The proportion of reactors in LP dairy herds rose sharply after six
years of age (Fig 5.2); seroprevalence amongst cattle aged nine years
or more was higher than average in D5, D7, D22 and D23 (Table 5.7).
Only three suckler herds (S19, S20, S27) showed marked increases in
seropreval ence indicative of extensive virus circulation. These were
also herds identified previously as having a high prevalence of BHV1
antibodies (>40 per cent). Instead of commencing amongst recently
calved heifers, seroconversion in the HP suckler herds appeared to
start at between one and two years of age and to continue at a lower
rate after calving than in HP dairy herds. The age-specific
prevalence pattern in LP suckler herds (Fig 5.3) was virtually
identical to that recorded in LP dairy herds (Fig 5.2).
DISCUSSION
The 55 herds included in this study represented about nine per cent
of all dairy and suckler herds containing 10 or more cows listed in
the 1989 agricultural census for Norfolk (MAFF 1990) (Chapter 2).
The extent of BHV1 infection in this sample population was
essentially unknown before investigations commenced: apart from D13
which had experienced an epidemic outbreak eight years previously,
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none of the herds had any clinical history of I BR. Significantly,
the prevalence of BHV1 antibodies (15.1 per cent) was virtually
identical to that in sera from apparently healthy cattle featured in
the analysis for 1980 - 1989 described in the previous chapter.
Furthermore, if the four (large) herds with a recent history of
IBR/vaccination had been included in these studies instead of being
excluded at the outset, overall seroprevalence, and the proportion of
heavily infected herds, would have been close to previous estimates.
The large proportion of herds with a low prevalence of BHV1
antibodies appeared similar to the situation in Germany (Forschner
1988) and Spain (Espuna and others 1988). The latter authors lent
further support to the present studies by also finding that herds
tended to be either heavily or lightly infected, with few having
intermediate seroprevalence.
The significant correlation between herd size and the number of
reactors in suckler herds appeared mainly to reflect a tendency for
larger suckler herds to contain more purchased cattle. On average,
suckler herds contained more than twice as many purchased cattle as
dairy herds. The four largest dairy herds (Dl, D5, D17, D23) had
purchased a total of only 13 replacements during the previous
10 years.
The strong association between reactor status and purchase supported
the generally accepted view (Gibbs and Rweyemamu 1977, Pastoret and
others 1984) that BHV1 is most frequently introduced by the addition
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of latently infected carriers to susceptible herds. Remarkably,
however, purchased adult cattle - including many that had been in the
herd for several years - were the only reactors detected in 16 of the
40 infected herds, suggesting that no virus transmission had occurred
following their introduction. Similarly, in LP herds in which some
young homebred cattle were also reactors, anecdotal information often
suggested sources of infection other than lateral spread from
seropositive purchased animals. In S4, for example, the only
homebred reactor was a bull that had been loaned to a herd in the
south of England for four months before returning to Norfolk. In
D13, six of the eight homebred reactors had been in the herd during
the IBR outbreak recorded in 1981. No satisfactory explanation was
found for the exclusively homebred reactors in D9 and S33 but it was
assumed that they had acquired infection in unrecorded incidents,
similar to that in D10, in which a heifer broke in with a group of
other cattle.
Two of the homebred reactors in D18 were specifically identified as
having attended several agricultural shows. However, several other
large herds had exhibited cattle at six or seven major shows each
year for the previous 15 years without any evidence of them acquiring
infection from this source. Although detailed records were rarely
available to make any systematic risk assessment, the present
findings suggested that agricultural shows and similar livestock
events did not pose any major threat, particularly when there was
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only a short period of close contact with other cattle. Further
observations regarding show attendance are included in the next
chapter.
The extent to which virus transmission occurred within infected herds
was clearly linked to their seroprevalence. There was a marked
difference between LP and HP herds in the rate of seroconversion
amongst naive cattle, as illustrated by their contrasting
age-specific prevalence patterns. The antibody prevalence recorded
amongst adult cattle in HP herds was partly influenced by the timing
of the herd blood test in relation to the calving season -
proportionally fewer two-year-olds were likely to have seroconverted
if they were uncalved or had calved only recently when tested and had
not had time to encounter infection. The less well-defined
distinction between LP and HP status in suckler herds (compared with
dairy herds) was mainly the result of a high proportion of purchased
reactors being present in very small herds.
Overall, field observations suggested that, in LP herds, the risk of
virus being transmitted from seropositive cattle (including
vaccinates) to susceptible in-contacts was quite small. Although
reexcretion of latent virus is undoubtedly of potential
epidemiological importance, its role under natural conditions, in the
absence of experimental provocation, appears to have been
overestimated. Van Nieuwstadt and Verhoeff (1983) similarly found no
evidence of virus transmission for at least three years in eight of
20 dairy herds in Holland and Baker and others (1989) detected only a
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very low rate of transmission of liye intranasallv administered
vaccinal virus to co-mingled steers. Pastoret and others (1984)
commented that only about 60 per cent of infected cattle shed virus
after dexamethasone treatment which suggested that not all
seropositive animals are latent carriers.
Widespread virus circulation, manifested by a high rate of
seroconversion, was clearly evident in the seven herds with the
highest antibody prevalence. Presumably, these herds were initially
infected via purchased replacements or similar sources. Unlike the
situation in LP herds, the virus then appeared to have spread rapidly
to susceptible cattle, amongst which it was maintained sufficiently,
presumably by regular reactivation and reexcretion, to infect each
year's input of heifers. There were no discernible differences
between HP and LP herds in environmental or intercurrent disease
stress factors such as lungworm infestation (Msolla and others 1983)
likely to cause viral reactivation.
Edwards and others (1991) found that calves infected with BHV1
subtype 1 excreted more virus than those infected with subtype 2b
strains and it appeared likely (S Edwards, personal communcation)
that the apparent divergence in virus behaviour between LP and HP
herds was associated with different strains of virus, possibly beyond
the sensitivity of simple restriction endonuclease fingerprinting
techniques. This hypothesis was supported by the observation that
herd S27, which was formed entirely from cattle in S19, had assumed
the seroconversion pattern of its parent herd, as was evident by the
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presence of two homebred yearling reactors. A less likely
explanation for the contrasting rates of seroconversion was that one
or more particularly heavy shedders of virus were present in HP herds
but not in LP herds.
Corkish (1988) suggested that calves in suckler herds were more
likely to acquire infection from their dams than those in dairy herds
which were removed soon after birth. There was, however, no
serological evidence from any of the herds in these studies to
indicate that active infection had occurred amongst calves aged less
than a year. MDA invariably disappeared by about six months and as
noted by Bradley (1985) these calves did not seroconvert until after
joining the cow herd as recently calved heifers. Although sera were
examined from calves in only one (S27) of the three HP suckler herds,
consistently seronegative findings from calves in this age range in
LP suckler herds suggested that the likelihood of them acquiring
infection through sucking seropositive dams was small.
Seroconversion occurred amongst 12 - 24 month old heifers in HP
suckler herds but not in the HP dairy herds. This difference was
attributed to the management practice commonly adopted in suckler
herds, whereby maiden heifers were housed close to adult cattle
during the winter. Similar findings, including seroconversion to
BHV1 amongst yearlings, were noted in suckler herds in the north-west
of Scotland (N. G. Brookes, personal communication). In dairy
herds, replacement heifers were almost invariably maintained as
completely separate populations, on marsh or upland grazing, until
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they joined the milking herd after calving. Hence, provided they did
not acquire infection from outside sources, uncalved heifers from HP
dairy herds were seronegative on entering the milking herd.
Forschner (1988) similarly commented that the proportion of reactors
amongst young cattle was lower on farms where they were kept apart
from the adult herd. By comparing serological status with date of
calving it appeared that most seroconversion in HP herds occurred two
or three months after calving, coinciding with winter housing.
The increase in seroprevalence with age supported findings described
in Chapter 4. In LP herds the likelihood of cattle being reactors
did not increase until after six years whereas most cattle in HP
herds had seroconverted by this time. Regardless of prevalence
category almost 50 per cent of all cattle in infected herds, aged 10
years or more, were seropositive. The preponderance of reactors
amongst older animals suggested that the LP herds (particularly D5,
D7, D22 and D23) had been more heavily infected in the past, but with
regular routine culling, infection was gradually working its way out
of these herds. Provided it is not reintroduced, self-elimination of
BHV1 from LP herds appears to be inevitable in view of the lack of
spread to susceptible herd members. Van Nieuwstadt and Verhoeff
(1983) similarly suggested that BHV1 might disappear in the long-term
from herds in which no recent virus circulation had occurred.
Conversely, BHV1 infection was likely to be maintained indefinitely
in HP herds unless there was a change in virus behaviour or in some
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factor not apparent from these studies. There was no obvious
explanation to account for the presence of eight seronegative cows
from amongst the 57 aged 10 years or more in the seven HP herds.
Because of the high rate of virus circulation detected in HP herds,
further enquiries were made to check whether there had been any
clinical history that could possibly be attributed to BHV1 infection.
These revealed that in August 1989, four recently calved cows in D21
experienced pyrexia and milk drop; a further similar case had
occurred in October 1990. No BHV1 antibodies had been detected in
diagnostic blood samples taken from these cows at the acute stage of
illness but when they were eventually retested (for the CHS) in
February 1991 all five were found to have seroconverted to BHV1.
Although not conclusive because of the long time interval between
testing, this evidence suggested that the herd may have experienced
clinical recrudescence of the type identified in Chapter 3.
Further evidence linking recrudescence and HP status, also in the
absence of a history of epidemic IBR, subsequently emerged from D3.
At the time of the herd test in 1987 there was no clinical history of
BHV1 infection but several typical IBR recrudescences were
subsequently confirmed by paired serology amongst second and third
parity cows between 1989 and 1991. These findings in D21 and D3
supported observations made in Chapter 3 regarding the occurrence of
recrudescence in heavily infected herds.
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CHAPTER 6: ELIMINATION OF BHV1 INFECTION
Besides economic benefits attributable to the absence of clinical
disease, BHVl-free serological status confers potential advantages on
herd owners when selling breeding stock, semen or embryos,
particularly for export. The introduction of the CHS in 1987
increased awareness of the health status of cattle herds in Britain
and promoted interest in the elimination of BHV1 infection - already
underway in some other countries of the EC. The longitudinal studies
presented here examine the progress of those herds featured in the
previous chapter that subsequently undertook the CHS programme to
achieve and maintain freedom from BHV1 infection. The results in two
HP herds that adopted different strategies are also described.
MATERIALS AND METHODS
Serological testing
The laboratory criteria used to determine whether cattle were BHV1
reactors were as described in the previous chapter.
CHS testing programme
Procedures
Herds in which no BHV1 reactors were detected amongst cattle aged
^two years at the first blood test undertook a second qualifying test
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of all animals (including calves) at least four months later. After
two consecutive clear blood tests, herds were registered as having
achieved "IBR monitored negative" status (ADAS 1987) and were then
subject to annual periodic tests of all adult cattle.
If reactors were disclosed at the first or subsequent tests and the
owner wished to proceed with the scheme, these cattle were usually
retested immediately to eliminate misidentification or laboratory
error; if the result was confirmed they were either culled or put
into isolation. A repeat test (either of all cattle in the herd or
of those aged two or more years) was performed at least a month after
reactors had been segregated. Provided this test was negative, these
herds reverted to the testing programme outlined for herds with no
reactors at the first test.
In addition to the blood testing programme, owners agreed to comply
with scheme rules (ADAS 1987) which included restrictions on the use
of semen from BHVl-seropositive bulls and the strict maintenance of
farm boundaries to keep scheme cattle at least three metres apart
from cattle of unknown disease status. An "added-animals" procedure
was adopted for purchased replacement stock and after exhibiting at
agricultural shows: this required cattle to be seronegative for BHV1
when blood tested after at least a month in isolation, before being
allowed to join or rejoin the herd.
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Participating herds and data recording
Four dairy herds (Dl, D6, D10, D19) and 10 suckler herds (S2, S9,
SI1, S14, S15, S16, S21, S22, S24, S28) with no reactors aged two or
more years at the first test proceeded with the CHS programme to
reach IBR monitored negative status. The single reactors detected
amongst cattle aged less than two years (see Chapter 5) in three of
these herds (D10, S9, SI1) were removed at least four months before
the second tests were undertaken. Nine LP dairy herds (D5, D8, D9,
Dl1, D14, D15, D17, D18, D23) and 12 LP suckler herds (SI, S4, S6,
S7, S8, S10, S12, S13, S17, S18, S32, S33) undertook further testing
after removal of reactors.
Prospective studies were undertaken in the above 35 herds until
August 1991: serological results were recorded and tabulated
according to date (month/year) of the tests, the number of cattle
tested and the number of reactors. If new reactors were identified,
herd managers were consulted to determine the probable source of
infection and steps were taken to limit its spread; additional blood
testing was undertaken as appropriate. Attendance at agricultural
shows was recorded and results of post-show serological screening
tests were noted.
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High prevalence dairy herd
Background details
This CHS herd (designated D24) was located in East Suffolk and
experienced the outbreak of epidemic IBR described in_the addendum to
Chapter 3 (q.v. for details of management and husbandry practices).
In June 1988, when the herd was first screened for BHV1 antibodies,
31 (75.6 per cent) of 41 randomly selected cattle at least two years
old proved to be seropositive. All cattle aged a year or more were
subsequently tested in December 1988: 106 (84.8 per cent) of the 125
milking cows then in the herd were reactors but all the younger
cattle, including the 10 uncalved two-year-olds, were negative (Table
6.1). Of 10 cows that were seronegative in June 1988 and retested in
December 1988, four (all aged between two-and-a-half and four years)
had seroconverted to BHV1, confirming recent virus circulation and HP
status.
Elimination strategy
A plan was devised whereby the uncalved heifers and the 19
seronegative cows identified in December 1988 were to provide the
basis for a new BHVl-free milking herd to be established within three
years, without the need for any seronegative breeding replacements to
be purchased.
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Table 6.1: Age-specific prevalence of BHV1 antibodies in D24





1 23 0 0
2 20 10# 50.0
3 26 19 73.1
4 25 23 92.0
5 17 17 )
6 8 8 )
7 7 7 ) 100*
8 6 6 )
9 8 8 )
>>10 8 8 )
No Number of cattle tested % Percentage of reactors
+ Number of reactors * All vaccinated in 1984/85
# All recently calved
Between January 1989 and June 1991, a non-infected group, initially
comprising the 19 seronegative cows, was managed separately from the
infected group (initially comprising 106 cows). Recently calved
homebred heifers were introduced into the negative group and infected
cows were gradually culled when convenient. Instead of allowing
heifers born in 1987 to calve as two-year-olds in 1989, service was
delayed in order to calve most as three-year-olds in 1990; most
1988-born heifers also calved in 1990, but as two-year-olds. These
management changes were adopted to allow as many seronegative cattle
as possible to be introduced simultaneously, having first reduced the
size of the infected group. Heifers were served exclusively by a
BHVl-seronegative bull and kept strictly apart from the main herd
until they calved. No cattle were exhibited at agricultural shows or
sales.
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The seronegative cows were milked first and had no direct contact
with the reactors either in the milking parlour or the collecting
yard; separate equipment and utensils were used for infected and
uninfected groups as far as was practicable. The two groups were
grazed separately and had no direct contact whatsoever between the
months of April and September. There was insufficient accommodation
to house them totally apart during the winter but contact was
minimised by dividing up the strawed yard (Fig 6.1). In 1989 and
1990, the small negative group occupied section A; in 1991 the
expanded negative group went into sections B, C and D and the

























Fig 6.1 : Layout of buildings used to house cattle in D24
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Some head-to-head contact was still possible between cattle in
sections A and B through unenclosed metal gates which were moved to
provide an extra standing area during milking; a mechanical feeder,
about two metres wide, separated most of sections A and D.
In addition to segregation, the reactors were vaccinated with
"Pneumovac Plus" (C-Vet Limited) in an attempt to reduce virus
shedding during winter housing by following the approach adopted in
Germany (Meyer and other 1985, Forschner 1988, Wittkowski 1990) as
discussed in the literature review. This inactivated (multivalent)
BHV1 vaccine had been used for this purpose in Germany until fairly
recently (G D Bell, personal communcation). Seropositive cattle
received two 2ml doses of the vaccine, intramuscularly in January and
February 1989 (about four weeks apart); those still in the infected
group were revaccinated in November 1989 and September 1990. The
seronegative group was blood tested every two to six months to
monitor progress: any new reactors were moved into the positive group
and vaccinated. Results were tabulated to show the date
(month/year) of each blood test, the number of cattle in infected and
uninfected groups and the number of new reactors.
High prevalence suckler herd
Background details
This herd (listed as S20 in the previous chapter) comprised about 100
adult cattle and 150 followers in April 1990. The cows were managed
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in four separate groups each containing at least one bull; calving
mainly took place in the months of December and January. Some of the
female calves were retained as breeding replacements to calve at two
to two-and-a-half-years of age; the remaining calves were fattened
intensively. Uncalved heifers were grazed separately from the cows
but all age groups, including fatteners, were housed together during
the winter.
Fifteen (55.6 per cent) of 27 randomly selected cows were
seropositive for BHV1 at an initial part-herd screening test in
November 1989. A subsequent herd test in April 1990, of all 154
cattle aged at least nine months (ie to avoid MDA), revealed that
73 (47.4 per cent) were seropositive, as were 55 (44.0 per cent) of
the 125 aged two or more years; the full age-specific prevalence
pattern was shown in the previous chapter (Table 5.8). One of the
12 cows (a three-year-old) that were seronegative in November 1989,
had seroconverted by April 1990, thereby confirming recent virus
circulation in the herd.
Elimination strategy
The plan was to attempt to reduce virus circulation - particularly
the high rate of seroconversion amongst heifers - for at least a year
and then to embark on a formal test-and-cul1 programme. The
management system did not readily lend itself to group segregation
and it was therefore proposed to rely entirely on vaccination (as
described for D24) to reduce or stabilise virus shedding. No
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additional procedures were adopted apart from ensuring that no other
BHVl-seropositive cattle entered the herd. For ease of management
and to reduce costs, testing for BHV1 to monitor progress was
undertaken to coincide with the qualifying and periodic tests for the
EBL Attested Herd Scheme (Chapter 5).
All reactors at least nine months old identified in April 1990 were
vaccinated with "Pneumovac Plus" in May 1990 and revaccinated four to
six weeks later. All previous non-reactors and other cattle that had
by then reached nine months of age were tested in September 1990: any
new reactors were vaccinated as above. All reactors first identified
in April 1990 received a booster vaccination in October or
November 1990 before calving. Non-reactors and previously untested
cattle aged at least nine months were examined for BHV1 antibodies in
May 1991. The numbers of new reactors detected at each blood test




As shown in Table 6.2, a reactor was found in only one of 32 second
or subsequent tests (involving a total of 3138 sera) performed over a
period extending to almost four years in the 14 herds that were
uninfected at the first test. The reactor (in SI1) was a
three-year-old heifer that had been seronegative when tested on three
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DateMonth/Y ar Noumberofcattltested*Singlre c or<2yearslddet cafi tt s +Numberofreactors#Suspe edvaccinate
previous occasions and was one of four suspected vaccinates imported
from continental Europe two years previously. One other member of
this group was seropositive when first tested as a yearling
(Table 5.6) and had since been culled.
Low prevalence herds
Herd managers were often reluctant to sell large numbers of reactors
at once and frequently opted for their phased removal over several
months or longer (ie 19 months in D9 and 11 months in D17) and made
no special efforts to keep them segregated until a month before the
second test.
BHV1 antibodies were found in five herds (eight cattle) from 45
second and subsequent tests, (involving a total of 5,506 sera),
undertaken after the removal of the initial reactors. In four of the
herds (D17, S10, S12, S33) new reactors were detected at the repeat
test (Table 6.3) performed after removal of reactors from the first
test. In S8, reactors were detected after at least 19 months freedom
from infection (Table 6.3); details of this incident are given in the
next section.
The three reactors in D17 (cows aged three, six and eight years) were
identified 11 months after the initial test. Two of these reactors
had calved during the previous four months: for two weeks before
parturition, and on the day of parturition, they had been in close
proximity to known reactors (awaiting culling) that calved at the
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DateMonth/Y ars Noumberofcattletested■ +Numberofreactors# *Part-herdbreakdown(d scribeint xt)
Seetextford tails Undertakenatleastonmonthfterr movalfreactors SeeTabl s5.1and2(Chapter)
same time, The calves born to the new reactors were seronegative for
BHV1 when tested at two and four months of age. In S12, a
four-year-old cow seroconverted during the five month period between
tests. Unlike in D17, reactors from the first test had been moved to
a separate farm as soon as they were identified leaving no
opportunity for further contact with seronegative cattle.
In S10, further enquiries indicated that the reactor may have been
misidentified when first tested and was probably not a new case. A
five-year-old cow in S33 which gave consistently inconclusive results
with the ELISA test but which was marginally seropositive with the
24 hour SNT (titre 1/2) was eventually classified as a reactor even
though it appeared very unlikely that it was actually infected.
Reinfection of S8
During the summer of 1990 most of the cattle (58 cows) in this herd
went out to marshland grazing, apart from a group of six cows with
calves at foot, and a two-year-old bull, which remained on upland
pasture close to the home farm. In August 1990 an apparently healthy
yearling steer of unknown BHV1 status, from a neighbouring farm,
broke through double fencing to gain access to the separate group of
13 cattle. The period of time during which direct contact occurred
was unknown but it was probably only a few hours. The group remained
clinically healthy and the owner decided, without consultation, that
the risk of introducing BHV1 had been minimal and chose to ignore the
incident apart from improving the fencing.
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The main herd returned from marsh grazing in November 1990 and was
subdivided into groups B, C and D and housed in a well ventilated
purpose-built cattle yard (Fig 6.2). The 13 cattle (group A)
returned to the farm buildings on 22/11/90. The herd remained in
separate groups during the winter: group A was separated from the
cows in group B by a metal gate which permitted head-to-head contact
but was kept apart from groups C and D by a three-metre wide feeding
passage.
On 29/11/90 all 65 cattle aged two or more years were blood sampled
for the annual periodic blood test for BHV1. Group A was put through
the race and crush separately from the rest of the herd and there was
40 m
Y
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no direct contact with the other groups. The serological results
(Table 6.4) showed that the bull and cow 1 (both in Group A), were
BHVl-positive but the rest of the herd was seronegative. The
reactors were isolated as soon as the results were known and the rest
of Group A (including the calves) was further separated from the
adjacent Group B by installing a three metre barrier of metal gates
(shown as X in Fig 6.2); no other suitable isolation facilities were
available to house this number of cattle.
The remaining 11 cattle in Group A were retested on 10/12/90,
revealing a further reactor - the 10-month-old calf of cow 1. This
was removed and the cattle still left in Group A, and all of Group B,
were retested on 17/1/91. No reactors were found amongst Group B,
but a further reactor, a four-month-old calf (calf 2) was detected in
Group A. This calf was removed and the entire herd of 126 cows and
calves was retested on 27/3/91 revealing two further reactors, both
in Group A - a recently calved cow (cow 3) and her 10-week-old calf.
Another reactor (cow 4) was detected in Group D, which was housed in
a yard located on the opposite side of the feeding passage. The
three new reactors were removed on 30/3/91 and the entire herd
retested on 2/5/91: no further reactors were detected. The
(isolated) calf of cow 4 (born 16/12/90) was seronegative for BHV1.
None of the cattle that seroconverted showed any clinical signs of
IBR.
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Table 6.4 : New BHV1 reactors detected in blood tests performed
after reinfection of S8
Date *
of Group Identity of Date reactors
Test A B C D new reactors removed
29/11/90 2 0 0 0 Cow 1
Bull
5/12/90
10/12/90 1 NT NT NT Calf of cow 1 16/12/90
17/ 1/91 1 0 NT NT Calf 2 27/ 1/91
27/ 3/91 2 0 0 1 Cow 3
Calf of cow 3
Cow 4
30/ 3/91
2/ 5/91 0 0 0 0 - -
* See Fig 6.2 NT Not tested
Attendance at Agricultural Shows
Twenty-seven (77.1 per cent) of the 35 herds undergoing the CHS
programme exhibited regularly at up to seven major agricultural shows
each year during the surveillance period: no new reactors were
detected in the show groups in any of these herds.
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High prevalence dairy herd
Most reactors were culled during 1990 and 1991 to coincide with the
main influx of heifers; a few remaining reactors were sold shortly
before the final test in June 1991 which confirmed that BHV1
infection had been eliminated within two-and-a-half years. A total
of three new reactors were detected (Table 6.5) during this period
and were put into the positive group. In addition, an IR detected
2/89 was initially moved into the infected group where it remained
for several months before rejoining the uninfected cows after proving
to be seronegative with the 24 hour SNT.
Table 6.5: Elimination of BHV1 infection from D24
Date of test Number of cattle
(Month/year) Positive group* Negative group New reactors
12/88 106 19 0
2/89 103 19 0
4/89 102 19 1
8/89 100 26 0
12/89 91 27 0
6/90 91 30 2
9/90 63 74 0
4/91 30 88 0
6/91 0 86 0
* Not retested after 12/88
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Table6.6:St bilisationofBHV1infection20 Year of BirthAgein years at4/90Non-reactors at4/90
Non-reactors from4/90 retested9/90
Newr actors detected 9/90
Non-reactors from9/90 retested5/91
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High prevalence suckler herd
Antibody prevalence amongst cattle aged at least nine months declined
from 73 (47.4 per cent) of 154 animals tested 4/90 to 55 (43.1 per
cent) of 151 tested 9/90 and 54 (39.1 per cent) of 138 tested 5/91.
Table 6.5 shows the number of new reactors detected according to age
cohort; some cattle were sold as the result of management policies
unrelated to BHV1 status and could not be retested. Of the 81
non-reactors from 4/90, 78 were retested 9/90 and 13 (16.7 per cent),
including seven three-year-olds, had seroconverted. None of the
17 calves that were less than nine months old and therefore not
previously tested, were positive at the 9/90 test but one born in
February 1989 and inadvertently omitted from the 4/90 test, was found
to have seroconverted.
At the final test carried out 5/91, there was no evidence of new
infection amongst the 62 cattle that were negative at all previous
tests or amongst the 19 that were too young to be tested earlier.
Seroconversion was not detected in any cattle born after April 1989.
DISCUSSION
The relative ease with which BHV1 was eradicated from LP herds using
a simple test-and-removal approach supported previous observations
concerning the virtual absence of virus circulation in these herds.
Excluding the apparently misidentified reactor in S10, and the
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anomalous IR in S33, virus transmission had occurred between
qualifying tests in just two herds (S12, D17). Both of these
initially contained quite large numbers of reactors which inevitably
increased the potential for naive animals to be exposed to infection.
However, spread of virus was not detected in other herds such as D5
or D23 which contained similarly large numbers of reactors at the
first test.
The adoption of a phased programme for the removal of reactors from
LP herds generally appeared to be justifiable since it enabled
producers to sell when cull cow prices were favourable or after
reactors had calved. In D17, however, it appeared that this somewhat
casual approach to eradication was responsible for spread of virus to
three other cows. In this herd, the findings suggested that
parturition provided the stress factor (Thiry 1985) that precipitated
viral reexcretion and transmission by known reactors still in the
herd: had infection been transmitted more than about two weeks before
parturition then the calves born to the reactors would almost
certainly have been seropositive for BHV1 through MDA. The evidence
from D17 suggested that the small risk of virus transmission by
retained reactors in LP herds could be reduced by segregating them at
calving.
Elimination of BHV1 infection from HP herds required a more
aggressive approach than that adopted in LP herds: a simple
test-and-cull programme was not feasible because of the high rate of
virus transmission. However, test-and-removal at short intervals was
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used to successfully eliminate rapidly spreading infection from S8,
This herd originally contained four reactors - all foundation herd
members - when first tested in December 1988. The apparent lack of
virus transmission to other cattle in the herd from these initial
reactors contrasted markedly with the rapid spread to a total of
seven cattle (about one new case per month) after the virus
(presumably a different strain) was reintroduced two years later
following a breach in herd security. It seemed probable that if
virus transmission had been left unchecked this herd would soon have
reached HP status.
In S20, vaccination alone proved surprisingly successful in halting
the spread of virus. Preliminary serological findings in this herd
had indicated that virus circulation amongst yearlings born in 1989
was superimposed on the typical HP herd pattern of seroconversion
after first calving. No significant changes in management practice
were adopted in this herd between 1989 and 1990, yet with the
commencement of the vaccination programme no new reactors were found
amongst cattle born after April 1989. This evidence suggested that
virus ceased circulating after the third dose of vaccine, which
supported similar claims by Forschner (1988). Wittkowski (1990)
noted a three to five per cent quota of new reactors in heavily
infected herds in Bavaria following a similar vaccination-based
eradication programme even though the overall proportion of
seropositive cattle declined by nine or 10 per cent annually.
Unfortunately S20 was dispersed later in 1991 and the period of the
trial could not be extended.
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It was difficult to assess whether the elimination of BHV1 infection
from D24 was achieved by separation alone or whether vaccination
played a significant part. On-farm circumstances unfortunately
dictated that separation between infected and uninfected groups was
not complete: reliance was therefore placed on vaccination to reduce
virus shedding and transmission during the critical winter housing
period although the time period (nine to 10 months) before
revaccination was greater than the six months advised by
Forschner (1988). In the event, the detection of three new reactors
was not unacceptable. After initial failure when relying on
separation alone, Ackerman and others (1990b) subsequently eliminated
BHV1 from a calf fattening unit when additional strict hygiene
precautions - far more stringent than those adopted here - were
introduced.
The inevitable constraints imposed on field trials performed under
farm conditions meant that it was not feasible to set up control
groups for the strategies adopted in D24 and S20. However, the
previously established histories of extensive active infection in
these herds provided some basis for comparison. Whilst the results
were encouraging, it must be accepted that the studies were not
exhaustive and further similar longer-term investigations, including
assessments of the effect of repeated vaccination on humoral antibody
titres, are needed to verify the findings.
Reactor misidentification and inconclusive test results were subjects
frequently raised by farmers. It was inevitable that
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misidentification occurred occasionally in blood tests involving
large numbers of animals sampled under farm conditions: similar
problems were noted by Wittkowski (1990). Fortunately, owners
invariably agreed to have reactors retested as a safeguard against
potentially costly mistakes, several of which were averted by such
action. Regarding the question of IRs, a simple cut-off point with
the ELISA test was originally envisaged to separate reactors from
non-reactors. Howeve", it soon became clear that although the ELISA
test performed consistently well for herd screening purposes it
tended to lack specificity at low antibody titre. Although an IR
category requiring resampling was subsequently introduced, it was not
until 1990, when the 24 hour SNT was routinely used for IRs that the
main difficulties were overcome. A few cattle (<0.2 per cent) were
consistently IRs with ELISA and although most of these subsequently
proved to be seronegative with the 24 hour SNT, owners usually
decided to cull them because of their potential nuisance value in
eradication programmes. Animals showing fluctuating inconclusive
results with ELISA often had a history of vaccination or suspected
vaccination.
Once BHV1 had been eliminated, herds remained free of infection
during the follow-up period despite regular attendance at
agricultural shows or sales where cattle were often housed close to
others of unknown BHV1 status for several days. These observations
further indicated that reactivation and reexcretion of BHV1 is an
uncommon event, even in the apparently stressful environment of the
show ring. However, if a virus strain of the type that reinfected S8
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was in circulation then rapid spread and widespread seroconversion
could be envisaged.
The one month isolation and testing routine used for added-animals
proved to be a successful precautionary measure for keeping infection
out of seronegative herds. It was used not only for show animals and
purchased replacements but also for calves born to reactors. In the
latter situation, where adequate isolation facilities were available
(preferably on separate premises) owners often continued to breed
from seropositive cows, subsequently introducing their calves into
the negative herd after they had been tested seronegative for BHV1 at
least a month after MDA had disappeared - usually by about six
months. One herd (S4) retained a seropositive bull on a separate
farm and used it on successive groups of seronegative heifers for
three seasons. The heifers were removed from the bull and tested for
BHV1 antibodies after a month's isolation: none of them seroconverted
despite being in close contact with the bull for periods of up to
three months.
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CHAPTER 7: GENERAL DISCUSSION AND MAIN CONCLUSIONS
Norfolk, with its numerically small cattle population, widely
dispersed within a predominantly arable landscape, provided an ideal
area in which to undertake this form of study. Two main sources of
information were available to the author: heterogeneous diagnostic
submissions to Norwich VIC and data from CHS herds. Each related to
essentially different, yet sizeable sections of the target population
and when considered together provided a comprehensive basis for
epidemiological analysis.
Unlike experimental investigations performed under controlled
conditions, observational field studies can suffer from numerous
constraints on data collection (Thrusfield 1988) but apart from
inevitable sample bias no significant problems were encountered here.
Because of regional differences in stock concentrations, husbandry
methods and disease prevalence, attempts to extrapolate the present
findings to herds elsewhere in Britain should be undertaken
guardedly. However, it was reassuring to note that the main
conclusions were supported by similar observations made to the author
by veterinary colleagues elsewhere including general practitioners
and those in the SVS responsible for CHS herds in other parts of
Britain.
Although IBR failed to emerge as a serious threat to cattle herds in
Norfolk during the 1980s, outbreaks occurred sporadically and by 1989
clinical disease had been confirmed (mainly by FAT or paired
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serology) in about 11 per cent of dairy herds and five per cent of
suckler herds in the county. In rearing/fattening herds the disease
was seen mainly during the winter months but outbreaks in adult
breeding cattle occurred throughout the year.
Retrospective analysis of laboratory serological submissions
indicated that BHV1 antibodies were widely distributed in Norfolk
herds. The best estimate (based on abortion serology) suggested that
about 28 per cent of adult cattle were seropositive; 44 per cent of
herds contained at least one reactor. The overall findings,
including crude comparisons with seroprevalence in CHS herds in other
regions (LAS Gibson, personal communication) suggested that cattle
in Norfolk had a slightly lower prevalence of BHV1 infection than
those in Britain as a whole. It should be appreciated, however, that
the seroprevalence (15.1 per cent) amongst cattle in the 56 CHS herds
featured here was artificially low because four large herds with a
recent clinical history of IBR and vaccination were excluded from the
study population at the outset.
The analysis of archival data highlighted the importance of
recrudescence as a recognisable clinical entity in endemically
infected herds. In the literature the term "recrudescence" has been
used mainly to describe reactivation and reexcretion of infection by
latently infected carriers rather than resurgence of disease amongst
immunologically naive in-contacts, which appeared to account for most
incidents recorded here. The significance of clinical recrudescence
has been virtually ignored by previous authors yet in dairy herds it
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accounted for almost as many confirmed I BR outbreaks as did epidemic
disease: significantly, VIDA II fails to distinguish between epidemic
and recrudescent disease outbreaks. In addition to causing economic
loss, recrudescence is an outward demonstration of virus circulation
in affected herds - a factor of major importance when considering
programmes to eliminate infection. Observations from CHS herds
supported the hypothesis that overt recrudescence is essentially
a feature of herds with a high antibody prevalence. Despite sporadic
recrudescences, most BHV1 infections in these herds appeared to be
subclinical although anecdotal evidence suggested that some HP herds
had experienced previously unrecognised morbidity associated with the
spread of virus amongst naive young cows.
The widely differing rates of virus transmission in HP and LP herds
were probably attributable to infection with different strains of
virus but it was beyond the scope of these studies to investigate
this aspect further. Individual herd histories showed that HP status
sometimes followed epidemic IBR outbreaks but this was not an
inevitable sequel: some HP herds had no history of epidemic disease.
In all four HP dairy herds antibody prevalence amongst adult cattle
exceeded 60 per cent, whereas it was somewhat less in two of the
three HP suckler herds. This probably reflected management and
husbandry factors instead of inherently different patterns of virus
activity. The relatively small average herd size and higher
proportion of purchased animals accounted for the wider
seroprevalence range in LP suckler herds compared with LP dairy
herds. Regardless of herd type, virus circulation is likely to be
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negligible if seroprevalence amongst adult cattle is less than 20 per
cent whereas extensive active infection is almost certainly present
if it exceeds 60 per cent. In herds of intermediate prevalence the
seroconversion pattern should be examined in relation to herd size,
management practices and origin of reactors before defining status.
Previous authors have commented that IBR outbreaks are often preceded
by the introduction of added-animals. Similar observations were made
with outbreaks in Norfolk as noted in Chapter 3. However, clinical
disease outbreaks suprisingly failed to follow the introduction of
presumably latently infected carriers into susceptible CHS herds.
This supported the contention that reactivation and reexcretion of
latent virus is a relatively uncommon event under natural conditions
although it could also be attributable to low virulence (including
vaccinal) strains of virus.
The association between reactor status and purchase appeared partly
to reflect a higher antibody prevalence in herds located outside
Norfolk from which most purchases were derived. The subsequent lack
of spread from purchased reactors made them appear all the more
\j
conspic/ous in herds that otherwise contained few, if any,
seropositive cattle.
A small number of homebred reactors were present amongst second and
third parity cows in LP herds. These were probably the result of
outside contacts with infected cattle or virus transmission from
older (often purchased) reactors in the same herd. Where there were
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substantial numbers of homebred reactors in this age range (ie
two-and-a-half to five years) it was invariably an indication of HP
status. With some 50 to 75 per cent of young cows in HP herds likely
to have seroconverted, only a few (ideally homebred animals) would
need to be sampled for BHV1 antibody screening to ascertain the
seroconversion pattern of individual herds. This approach would
provide a low-cost alternative to the initial whole or part-herd
screening tests for BHV1 infection currently used in the CHS. Once
the BHV1 status of herds has been established, owners can be advised
on appropriate methods to control or eliminate the infection.
It is widely recognised that semen from infected bulls is a potential
source of BHV1 infection, either through natural service or AI. With
the introduction of strict measures to control IPV/IPB, most bulls
now held at AI studs in Britain are seronegative for BHV1 and semen
from the few seropositive bulls is routinely examined for the
presence of virus before use. It was not possible from these studies
to assess the possible role of semen in the transmission of BHV1 in
Norfolk herds during the 1980s: virtually all herds used AI and even
if semen transmission had occurred despite precautions, as in the
incident reported by Kupferschmied and others (1986), this route of
spread was almost certainly of minimal significance compared with the
effects of purchased reactors and other direct contacts with infected
cattle.
BHV1 also has the potential to be passively carried by embryos during
ET activities but in his review, Straub (1990a) concluded that this
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did not pose any significant risk and there was no circumstantial
evidence from these present studies to suggest that the virus had
been introduced by this means. ET recipients were frequently
seropositive through vaccination but as with other seropositive dams
their calves were invariably negative for BHV1 antibody by about six
months of age.
Although not specifically examined here, there v/as no circumstantial
evidence to suggest that long-distance airborne spread occurred with
BHV1 as has been demonstrated with ADV, which is also an
alphaherpesvirus (Gloster and others 1984). The possibility of
infection being acquired through contact with other ruminants
(Straub 1990b) was similarly undetermined although it appeared to be
unlikely. Nixon and others (1988) suggested that testing deer or
goats was unnecessary for BHV1 control programmes.
It was evident both from the analysis of diagnostic data and from CHS
serological findings that antibody prevalence was at its lowest
amongst cattle aged between six and 12 months (ie after MDA had
declined). This supported clinical observations presented in
Chapter 3 regarding the relatively low incidence of disease amongst
this age group. Antibody prevalence subsequently increased with age
after first calving, coinciding with heifers returning to their
parent herds from separate grazings. Although antibody prevalence
increased at contrasting rates in the CHS LP and HP herds, by
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10 years of age nearly 50 per cent of all cattle tested were
reactors, regardless of the antibody prevalence category of the herds
involved.
Clearly, the longer that susceptible cattle remain in infected herds
the more likely they are to acquire infection and seroconvert.
However, in LP herds, seroprevalence generally remained low until
about six years of age before rising sharply. This suggested that
BHV1 infection may previously have been more prevalent in these herds
but, unlike in HP herds, it had subsequently failed to maintain
itself. Provided infection is not reintroduced, LP herds with their
intrinsically slow rate of virus spread, might be expected to
eventually achieve seronegative status of their own accord merely by
the routine culling of older (and mainly seropositive) cattle.
It is common management practice in dairy herds, but to a lesser
extent in suckler herds, for replacement heifers to be reared
completely separately from the adult herd until after first calving.
The disadvantage of this approach for disease control is that it
fails to naturally immunise young cattle against infections endemic
in the adult herd. The present observations indicated that the
arrival of naive heifers into HP herds sometimes provoked
recrudescent outbreaks of IBR: analogous findings were noted by
Hathaway and Little (1983) amongst second parity cows in dairy herds
endemically infected with Leptospira interrogans serovar hard.io.
Despite this drawback, rearing heifers apart from the adult herd
permits the establishment of a population of seronegative breeding
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cattle of the main age range for national and international trading
purposes, despite high levels of residual infection being present in
the main herd. This explained why some owners had successfully
exported young BHVl-seronegative cattle without realising that their
adult herds contained numerous reactors.
The apparent absence of virus transmission in most infected herds
suggested that the excessive provocation afforded by the high doses
of corticosteroid used in experimental reactivation studies may not
be relevant to the field situation. Observations in one CHS herd
(D17) supported the findings of Thiry and others (1985) regarding the
role of parturition as a stimulus for virus reexcretion. Reactors
retained pending culling from herds undergoing programmes to
eliminate BHV1 infection should therefore be calved in isolation. It
would also be advisable for them not to receive corticosteroid
therapy, even though dose rates used in veterinary practice are
somewhat less than those used experimentally.
In LP herds, BHV1 infection was readily eliminated by following a
simple test-and-cul1 approach, phased if necessary over a period of
months or even years. By adhering to CHS rules governing added
animals and contact with cattle of unknown BHV1 status, herds
subsequently remained free of infection during the follow-up period,
despite continued attendance at agricultural shows. However, the
introduction of rapidly spreading infection in one IBR monitored
negative herd sounded a note of caution regarding the possibly
disastrous consequences of failing to maintain adequate farm
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boundaries and other disease security precautions. Further
longer-term studies are needed to establish whether herds can remain
free of infection beyond the three to four years examined here.
The high rate of seroconversion amongst second and third parity cows
in HP herds presented a major obstacle to removing infection. In
these herds, strongly motivated owners could adopt programmes based
on separation and, or vaccination, similar to those described here.
They could even consider depopulating and restocking. However, in
most HP herds these were not economically viable options.
Furthermore, provided the young stock and the adult herd were kept
apart, owners could still confidently expect to maintain the enhanced
sale potential of seronegative heifers or bulls once MDA had waned.
In herds in which recrudescence was a problem, heifers could be
vaccinated intranasally with a modified live virus vaccine before
entering the main herd.
The strategic use of inactivated vaccines to reduce virus shedding by
latently infected carriers currently forms an integral part of
voluntary control schemes for BHV1 infection in Germany. It is not
clear from the German literature whether the apparently successful
use of inactivated vaccine to stabilise virus transmission applies
equally to herds in the high prevalence category and to those
containing only a few reactors (ie LP herds). As demonstrated in
these present studies, the latter herds would be expected to exhibit
only minimal virus shedding even without vaccination. Despite the
widespread promotion of these vaccination programmes there is
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little published scientific evidence to support their efficacy - a
conclusion also reached by Gibson and Edwards (1991). Furthermore,
the crucial concept that virus excretion is reduced if humoral
antibody titres remain high (Meyer and others 1985, Forschner 1988)
has recently been challenged by Straub (1991a). Also, in a recent
small study at the CVL, "Pneumovac Plus" failed to reduce the titre
of virus shed from experimentally infected calves following the
administration of dexamethasone (S Edwards, personal communication).
Despite these reservations, the use of inactivated vaccine in the
present studies seemed to be remarkably successful. Although the
contribution made by partial separation to the programme adopted in
D24 could not readily be separated from the effects of vaccination,
it appeared that vaccination alone had halted virus transmission in
S19.
Straub (1991a) has proposed a rather complicated control scheme for
BHV1 using either inactivated or live vaccines in a schedule based on
herd size and antibody prevalence rate. In the same publication the
author claims, without apparent scientific proof, that virus shedding
ceases after three doses of live intranasal vaccine have been
administered. Many questions concerning this whole topic remain
unanswered and there is clearly a need for further investigations -
preferably controlled field trials - to fully evaluate the effects of
vaccination on virus shedding by latently infected carriers.
It is noteworthy that some of the previously unreported
epidemiological findings from these present studies bear marked
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similarity to published work on ADV infection of pigs. This closely
related virus has been the subject of eradication and control schemes
in several European countries, including Britain (Watson 1986)
similar to those adopted for BHV1. ADV can also establish latent
infection resulting in clinical recrudescence several years later
(Basinger 1979) affecting up to about five per cent of adult pigs
(E N Wood, personal communication). Offspring of seropositive sows
can be raised as seronegative replacement stock (Thawley and others
1980) as demonstrated here with BHV1.
Several recent field studies with ADV infection in the USA have
revealed further close parallels with the epidemiology of BHV1
infection as observed in Norfolk herds. Annelli and others (1991)
found that ADV infection failed to spread in 23 of 27 herds
containing single reactors and they attributed this to low virulence
strains of virus rather than environmental factors. Similarly,
Morrison and others (1991) noted that 42 per cent of quarantined
herds contained less than 20 per cent of adult reactors. Claiming
this as a major new finding they concluded that ADV infection stops
spreading in most herds after the initial epidemic. Duffy and others
(1991) noted a positive association between the spread of ADV and the
housing of gilts in the same building as sows, which supports
comparable observations with BHV1 infection in HP suckler herds.
In Europe, interest in BHV1 infection is likely to increase during
the next few years. The removal of trade barriers and harmonisation
of animal health controls within the EC after 1992 will highlight
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regional differences in patterns of disease, including those caused
by BHV1. Recent EC directives have emphasised the importance of
BHVl-seronegative status for international trade in embryos and
semen. Compulsory eradication programmes for BHV1 are already
underway in Denmark and Switzerland; in Germany and France cattle
producers have been encouraged to join voluntary eradication schemes.
The introduction of the CHS belatedly awakened cattle producers in
Britain to the potential benefits of voluntary improvements in health
status and herd security - aspects of disease control that have been
well appreciated by other livestock sectors, particularly pigs, for
some years. Enthusiasm was partly dampened by export restrictions
imposed following the emergence of bovine spongiform encephalopathy
(BSE) (Wells and others 1987) but when export restrictions are
eventually lifted, the industry can be expected to show renewed
interest in eliminating BHV1 infection. Organisers of major
agricultural shows may even decide to follow the lead set by "Tier
und Technic '89, in Frankfurt, Germany, by regulating the BHV1 status
of cattle being exhibited.
After BSE and EBL, BHV1 infection is a possible choice for a national
eradication programme in Britain during the next decade. Whether
this occurs will depend on political and trade pressures. It is
hoped that the studies described in this dissertation have gone some
way towards improving the understanding of the epidemiology of BHV1
infection and will provide a useful basis for discussions concerning
its eradication at herd or national level.
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APPENDIX 3.2 : ABORTION REPORT FORM
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f 1.(a)Name and address ot owner
Postcode T®ioorion« No.
(b) Address where herd is keot (if different from aoovei
Postcode
Ear No. of Dam
Breed of Dam
A. Vaccination Status of 0 tm (tick aooroonate box)
None □ S19 Not known
5. Oate of aoortion / cafving
S. Place of abortion / calving (tick aDproDnate box)
r~""1 i—; i—• i—• r—'isolation box I ;stall I i yard I pasture | aisewnere | ;
7. 0S 27: has been served C has not been served |_—
3. Is Oam.
(Drevl0us normal.—
(a) Homeored I | Purcnased I calving in this nerd !
(b) IR □ Dangerous contact L_J Tracing |
(c) If so, is it in isolation? YES I NO I
9. Visit No. 1 I ! 2 ! i 3 or more □
Reoort to be sent
to Animal Health Office i
10. CPHHNo. |




210 — 239 days
240—269 days
270 days <£ over
Unknown
12. Calves bom: All live !
13. Date of samoling
Any de;id or
foetus not found
J"™; 14. Age of Dam (in years)
Note: Samoies submitted wtil be examined for evidence
of Brucella aocrtus infection. If additional examinations
for other pathogens are recuired oiease suomit a VIO 16
form with this farm giving ail relevant information
including the tosts required. These additional tests will





. IVI / VO
Laboratory Results


























f To be completed In Animal Health OHIca
15. Is this a normal
calving in an infected herd?
16. Is this enquiry r—
associated with tracing of a DC? YES L«J
17. Action
required
NO CIj Testresuit: Pass I ; Fail I j Inconclusive f""H
i—i i— i—r
NO '• : 19. Officer samoling: IVI MAFF Officer i
Signed ! 1DVO / VO Date j_
BS 7 (Revised 1989) 3AA / MAP 01 / PBQ2M / 20M12
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APPENDIX 5.1: CATTLE HEALTH SCHEME QUESTIONNAIRE
(Adapted from MAFF form CH3: details not applicable
to this study have been omitted)
1. Date of visit
2. CPH Number
3. Owner's name, address and telephone number
4. Address of Scheme (where "different/additional to 3i
5. Name, address and telephone number of farm manager jr agent
(if different to 3 above)
6. OS map reference number of Scheme premises
7. Type of herd: Dairy = D, Beef Suckler = S, Mixed = 0
8. Main breeds
9. Address of other herds in the same ownership





Fattening Heifer Dealer Other
rearer
Flying herd Self contained herd Open herd with purchased stock
12. If purchased give details of sources and total number of cattle purchased
in previous 10 years.
13. Method of mating cows:
14. Details of any movement/contact between this herd and any other herd in
different ownership
15. Agricultural show attendance - approximate number attended each year
16. Stock numbers:
Bui Is
Cows and heifers (over 24 months)
Heifers (between 12-24 months)
Young stock (other than steers)
Steers
Totals
17. Details of premises:
(a) Isolation of the herd - are the boundaries satisfactory with a
minimum separation of 3m between scheme and non designated stock?
(b) Describe isolation premises and state number of cattle that can be
accommodated and whether the premises can be cleansed and disinfected
(c) Are isolation facilities adequate for I BR control?
18. Is there more than one herd in the same ownership?
If yes, give details of contact between the herds
Own bull Hired/loaned bull AI ET
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19. Details of grazing policy:
Minimal grazing Seasonal grazing Total grazing
(a) Temporary grazing
(b) Communal grazing
20. Details of visitors and vehicles - describe routine precautions
21. If AI is used is the owner aware of the restrictions on the use of semen
from seropositive bulls?
22. Has I BR ever been diagnosed in the herd previous I/?
23. Has I BR vaccine been used in the herd?
24. Any other relevant information or remarks
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